ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0267-C.1 | ACTH (Adrenocorticotrophic Hormone); Clone 2F6 (Konsantre) | 0.1 ml |
RA0267-C.5 | ACTH (Adrenocorticotrophic Hormone); Clone 2F6 (Konsantre) | 0.5 ml |
RA0266-C.1 | ACTH (Adrenocorticotrophic Hormone); Clone 57 (Konsantre) | 0.1 ml |
RA0266-C.5 | ACTH (Adrenocorticotrophic Hormone); Clone 57 (Konsantre) | 0.5 ml |
RA0265-C.1 | ACTH (Adrenocorticotrophic Hormone); Clone AH26 (Konsantre) | 0.1 ml |
RA0265-C.5 | ACTH (Adrenocorticotrophic Hormone); Clone AH26 (Konsantre) | 0.5 ml |
RA0268-C.1 | ACTH (Adrenocorticotrophic Hormone); Clone AH26 & 57 (Konsantre) | 0.1 ml |
RA0268-C.5 | ACTH (Adrenocorticotrophic Hormone); Clone AH26 & 57 (Konsantre) | 0.5 ml |
RA0405-C.1 | Actin, Muscle Specific (Muscle Cell Marker); Clone HHF35 (Konsantre) | 0.1 ml |
RA0405-C.5 | Actin, Muscle Specific (Muscle Cell Marker); Clone HHF35 (Konsantre) | 0.5 ml |
RA0406-C.1 | Actin, Muscle Specific (Muscle Cell Marker); Clone MSA/953 (Konsantre) | 0.1 ml |
RA0406-C.5 | Actin, Muscle Specific (Muscle Cell Marker); Clone MSA/953 (Konsantre) | 0.5 ml |
RA0001-C.1 | Actin, Smooth Muscle (Leiomyosarcoma Marker); Clone 1A4 (Konsantre) | 0.1 ml |
RA0001-C.5 | Actin, Smooth Muscle (Leiomyosarcoma Marker); Clone 1A4 (Konsantre) | 0.5 ml |
RA0002-C.1 | Actin, Smooth Muscle (Leiomyosarcoma Marker); Clone ACTA2/791 (Konsantre) | 0.1 ml |
RA0002-C.5 | Actin, Smooth Muscle (Leiomyosarcoma Marker); Clone ACTA2/791 (Konsantre) | 0.5 ml |
RA0003-C.1 | AFP (Alpha Fetoprotein) (Hepatocellular/Germ Cell Tumor Marker); Clone C3 (Konsantre) | 0.1 ml |
RA0003-C.5 | AFP (Alpha Fetoprotein) (Hepatocellular/Germ Cell Tumor Marker); Clone C3 (Konsantre) | 0.5 ml |
RA0004-C.1 | AFP (Alpha Fetoprotein) (Hepatocellular/Germ Cell Tumor Marker); Clone FETA/810 (Konsantre) | 0.1 ml |
RA0004-C.5 | AFP (Alpha Fetoprotein) (Hepatocellular/Germ Cell Tumor Marker); Clone FETA/810 (Konsantre) | 0.5 ml |
RA0521-C.1 | Alpha-1-Antichymotrypsin (SERPINA3) (Histiocytoma Marker); Clone AACT/1451 (Konsantre) | 0.1 ml |
RA0521-C.5 | Alpha-1-Antichymotrypsin (SERPINA3) (Histiocytoma Marker); Clone AACT/1451 (Konsantre) | 0.5 ml |
RA0521-C1 | Alpha-1-Antichymotrypsin (SERPINA3) (Histiocytoma Marker); Clone AACT/1451 (Konsantre) | 1 ml |
RA0523-C.1 | Alpha-1-Antichymotrypsin (SERPINA3) (Histiocytoma Marker); Clone AACT/1451 & AACT/1452 (Konsantre) | 0.1 ml |
RA0523-C.5 | Alpha-1-Antichymotrypsin (SERPINA3) (Histiocytoma Marker); Clone AACT/1451 & AACT/1452 (Konsantre) | 0.5 ml |
RA0523-C1 | Alpha-1-Antichymotrypsin (SERPINA3) (Histiocytoma Marker); Clone AACT/1451 & AACT/1452 (Konsantre) | 1 ml |
RA0522-C.1 | Alpha-1-Antichymotrypsin (SERPINA3) (Histiocytoma Marker); Clone AACT/1452 (Konsantre) | 0.1 ml |
RA0522-C.5 | Alpha-1-Antichymotrypsin (SERPINA3) (Histiocytoma Marker); Clone AACT/1452 (Konsantre) | 0.5 ml |
RA0522-C1 | Alpha-1-Antichymotrypsin (SERPINA3) (Histiocytoma Marker); Clone AACT/1452 (Konsantre) | 1 ml |
RA0526-C.1 | AMACR / p504S (Prostate Cancer Marker); Clone AMACR/2748R (Konsantre) | 0.1 ml |
RA0526-C.5 | AMACR / p504S (Prostate Cancer Marker); Clone AMACR/2748R (Konsantre) | 0.5 ml |
RA0526-C1 | AMACR / p504S (Prostate Cancer Marker); Clone AMACR/2748R (Konsantre) | 1 ml |
RA0354-C.1 | AMACR / p504S (Prostate Cancer Marker); Rabbit Polyclonal (Konsantre) | 0.1 ml |
RA0354-C.5 | AMACR / p504S (Prostate Cancer Marker); Rabbit Polyclonal (Konsantre) | 0.5 ml |
RA0423-C.5 | AMP Deaminase, Isoform E (AMPD3) (Erythroid Marker); Clone AMPD3/901 (Konsantre) | 0.5 ml |
RA0010-C.1 | Androgen Receptor (Marker of Androgen Dependence); Clone AR441 (Konsantre) | 0.1 ml |
RA0010-C.5 | Androgen Receptor (Marker of Androgen Dependence); Clone AR441 (Konsantre) | 0.5 ml |
RA0012-C.1 | Androgen Receptor (Marker of Androgen Dependence); Clone AR441 & DHTR/882 (Konsantre) | 0.1 ml |
RA0012-C.5 | Androgen Receptor (Marker of Androgen Dependence); Clone AR441 & DHTR/882 (Konsantre) | 0.5 ml |
RA0011-C.1 | Androgen Receptor (Marker of Androgen Dependence); Clone DHTR/882 (Konsantre) | 0.1 ml |
RA0011-C.5 | Androgen Receptor (Marker of Androgen Dependence); Clone DHTR/882 (Konsantre) | 0.5 ml |
RA0457-C.1 | Arginase 1 (Hepatocellular Carcinoma Marker); Clone ARG1/1125 (Konsantre) | 0.1 ml |
RA0457-C.5 | Arginase 1 (Hepatocellular Carcinoma Marker); Clone ARG1/1125 (Konsantre) | 0.5 ml |
RA0457-C1 | Arginase 1 (Hepatocellular Carcinoma Marker); Clone ARG1/1125 (Konsantre) | 1 ml |
RA0458-C.1 | Arginase 1 (Hepatocellular Carcinoma Marker); Clone ARG1/1126 (Konsantre) | 0.1 ml |
RA0458-C.5 | Arginase 1 (Hepatocellular Carcinoma Marker); Clone ARG1/1126 (Konsantre) | 0.5 ml |
RA0458-C1 | Arginase 1 (Hepatocellular Carcinoma Marker); Clone ARG1/1126 (Konsantre) | 0.1 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0013-C.1 | Bax (Apoptosis Marker); Clone 2D2 (Konsantre) | 0.1 ml |
RA0013-C.5 | Bax (Apoptosis Marker); Clone 2D2 (Konsantre) | 0.5 ml |
RA0347-C.1 | BCL10 (MALT-Lymphoma Marker); Clone BL10/411 (Konsantre) | 0.1 ml |
RA0347-C.5 | BCL10 (MALT-Lymphoma Marker); Clone BL10/411 (Konsantre) | 0.5 ml |
RA0017-C.1 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone 100/D5 & 124 (Konsantre) | 0.1 ml |
RA0017-C.5 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone 100/D5 & 124 (Konsantre) | 0.5 ml |
RA0020-C.1 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone 100/D5 & BCL2/796 | 0.1 ml |
RA0020-C.5 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone 100/D5 & BCL2/796 | 0.5 ml |
RA0018-C.1 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone BCL2/782 (Konsantre) | 0.1 ml |
RA0018-C.5 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone BCL2/782 (Konsantre) | 0.5 ml |
RA0019-C.1 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone BCL2/796 (Konsantre) | 0.1 ml |
RA0019-C.5 | Bcl-2 (Apoptosis & Follicular Lymphoma Marker); Clone BCL2/796 (Konsantre) | 0.5 ml |
RA0015-C.1 | Bcl-2 (Apoptosis and Follicular Lymphoma Marker); Clone 100/D5 (Konsantre) | 0.1 ml |
RA0015-C.5 | Bcl-2 (Apoptosis and Follicular Lymphoma Marker); Clone 100/D5 (Konsantre) | 0.5 ml |
RA0016-C.1 | Bcl-2 (Apoptosis and Follicular Lymphoma Marker); Clone 124 (Konsantre) | 0.1 ml |
RA0016-C.5 | Bcl-2 (Apoptosis and Follicular Lymphoma Marker); Clone 124 (Konsantre) | 0.5 ml |
RA0024-C.1 | Bcl-6 (Follicular Lymphoma Marker); Clone IG191E/A8 (Konsantre) | 0.1 ml |
RA0024-C.5 | Bcl-6 (Follicular Lymphoma Marker); Clone IG191E/A8 (Konsantre) | 0.5 ml |
RA0024-C1 | Bcl-6 (Follicular Lymphoma Marker); Clone IG191E/A8 (Konsantre) | 1 ml |
RA0022-C.1 | Bcl-X (Apoptosis Marker); Clone 2H12 (Konsantre) | 0.1 ml |
RA0022-C.5 | Bcl-X (Apoptosis Marker); Clone 2H12 (Konsantre) | 0.5 ml |
RA0021-C.1 | Bcl-X (Apoptosis Marker); Clone BX006 (Konsantre) | 0.1 ml |
RA0021-C.5 | Bcl-X (Apoptosis Marker); Clone BX006 (Konsantre) | 0.5 ml |
RA0023-C.1 | Bcl-X (Apoptosis Marker); Clone BX006 & 2H12 (Konsantre) | 0.1 ml |
RA0023-C.5 | Bcl-X (Apoptosis Marker); Clone BX006 & 2H12 (Konsantre) | 0.5 ml |
RA0424-C.5 | Beta-2 Microglobulin (Renal Failure & Tumor Marker); Clone B2M/1118 (Konsantre) | 0.5 ml |
RA0425-C.1 | Beta-2 Microglobulin (Renal Failure & Tumor Marker); Clone B2M/961 (Konsantre) | 0.1 ml |
RA0425-C.5 | Beta-2 Microglobulin (Renal Failure & Tumor Marker); Clone B2M/961 (Konsantre) | 0.5 ml |
RA0104-C.1 | beta-Catenin (p120); Rabbit Polyclonal (Konsantre) | 0.1 ml |
RA0104-C.5 | beta-Catenin (p120); Rabbit Polyclonal (Konsantre) | 0.5 ml |
RA0378-C.1 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone 85-2C8 (Konsantre) | 0.1 ml |
RA0378-C.5 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone 85-2C8 (Konsantre) | 0.5 ml |
RA0377-C.1 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone BRD.3 (Konsantre) | 0.1 ml |
RA0377-C.5 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone BRD.3 (Konsantre) | 0.5 ml |
RA0372-C.1 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone BRD469 (Konsantre) | 0.1 ml |
RA0372-C.5 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone BRD469 (Konsantre) | 0.5 ml |
RA0374-C.1 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone BRD494 (Konsantre) | 0.1 ml |
RA0374-C.5 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone BRD494 (Konsantre) | 0.5 ml |
RA0375-C.1 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone BU20a (Konsantre) | 0.1 ml |
RA0375-C.5 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone BU20a (Konsantre) | 0.5 ml |
RA0376-C.1 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone MoBu-1 (Konsantre) | 0.1 ml |
RA0376-C.5 | Bromodeoxyuridine (BrdU) (Proliferation Marker); Clone MoBu-1 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0397-C.1 | CA19-9/Sialyl Lewisa (GI Tumor Marker); Clone 121SLE (Konsantre) | 0.1 ml |
RA0397-C.5 | CA19-9/Sialyl Lewisa (GI Tumor Marker); Clone 121SLE (Konsantre) | 0.5 ml |
RA0029-C.1 | Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker); Clone CALD1/820 (Konsantre) | 0.1 ml |
RA0029-C.5 | Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker); Clone CALD1/820 (Konsantre) | 0.5 ml |
RA0030-C.1 | Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker); Clone CALD1/820 & h-CALD (Konsantre) | 0.1 ml |
RA0030-C.5 | Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker); Clone CALD1/820 & h-CALD (Konsantre) | 0.5 ml |
RA0028-C.1 | Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker); Clone h-CALD (Konsantre) | 0.1 ml |
RA0028-C.5 | Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker); Clone h-CALD (Konsantre) | 0.5 ml |
RA0099-C.1 | Calponin-1 (Smooth Muscle Marker); Clone CALP (Konsantre) | 0.1 ml |
RA0099-C.5 | Calponin-1 (Smooth Muscle Marker); Clone CALP (Konsantre) | 0.5 ml |
RA0100-C.1 | Calponin-1 (Smooth Muscle Marker); Clone CNN1/832 (Konsantre) | 0.1 ml |
RA0100-C.5 | Calponin-1 (Smooth Muscle Marker); Clone CNN1/832 (Konsantre) | 0.5 ml |
RA0101-C.1 | Calponin-1 (Smooth Muscle Marker); Clone CNN1/832 & CALP (Konsantre) | 0.1 ml |
RA0101-C.5 | Calponin-1 (Smooth Muscle Marker); Clone CNN1/832 & CALP (Konsantre) | 0.5 ml |
RA0489-C.1 | Carcinoembryonic Antigen (CEA) / CD66 ; Clone SPM506 (Konsantre) | 0.1 ml |
RA0489-C.5 | Carcinoembryonic Antigen (CEA) / CD66 ; Clone SPM506 (Konsantre) | 0.5 ml |
RA0489-C1 | Carcinoembryonic Antigen (CEA) / CD66 ; Clone SPM506 (Konsantre) | 1 ml |
RA0488-C.1 | Carcinoembryonic Antigen (CEA) / CD66 ; Clone SPM541 (Konsantre) | 0.1 ml |
RA0488-C.5 | Carcinoembryonic Antigen (CEA) / CD66 ; Clone SPM541 (Konsantre) | 0.5 ml |
RA0488-C1 | Carcinoembryonic Antigen (CEA) / CD66 ; Clone SPM541 (Konsantre) | 1 ml |
RA0432-C.1 | Carcinoembryonic Antigen (CEA) / CD66; Clone C66/1009 (Konsantre) | 0.1 ml |
RA0432-C.5 | Carcinoembryonic Antigen (CEA) / CD66; Clone C66/1009 (Konsantre) | 0.5 ml |
RA0432-C1 | Carcinoembryonic Antigen (CEA) / CD66; Clone C66/1009 (Konsantre) | 1 ml |
RA0490-C.1 | Carcinoembryonic Antigen (CEA) / CD66; Clone C66/1030 (Konsantre) | 0.1 ml |
RA0490-C.5 | Carcinoembryonic Antigen (CEA) / CD66; Clone C66/1030 (Konsantre) | 0.5 ml |
RA0490-C1 | Carcinoembryonic Antigen (CEA) / CD66; Clone C66/1030 (Konsantre) | 1 ml |
RA0481-C.1 | Carcinoembryonic Antigen (CEA) / CD66; Clone C66/1260 (Konsantre) | 0.1 ml |
RA0481-C.5 | Carcinoembryonic Antigen (CEA) / CD66; Clone C66/1260 (Konsantre) | 0.5 ml |
RA0481-C1 | Carcinoembryonic Antigen (CEA) / CD66; Clone C66/1260 (Konsantre) | 1 ml |
RA0485-C.1 | Carcinoembryonic Antigen (CEA) / CD66; Clone C66/195 (Konsantre) | 0.1 ml |
RA0485-C.5 | Carcinoembryonic Antigen (CEA) / CD66; Clone C66/195 (Konsantre) | 0.5 ml |
RA0485-C1 | Carcinoembryonic Antigen (CEA) / CD66; Clone C66/195 (Konsantre) | 1 ml |
RA0083-C.1 | Carcinoembryonic Antigen (CEA) / CD66; Clone C66/261 (Konsantre) | 0.1 ml |
RA0083-C.5 | Carcinoembryonic Antigen (CEA) / CD66; Clone C66/261 (Konsantre) | 0.5 ml |
RA0084-C.1 | Carcinoembryonic Antigen (CEA) / CD66; Clone CEA31 (Konsantre) | 0.1 ml |
RA0084-C.5 | Carcinoembryonic Antigen (CEA) / CD66; Clone CEA31 (Konsantre) | 0.5 ml |
RA0082-C.1 | Carcinoembryonic Antigen (CEA) / CD66; Clone COL-1 (Konsantre) | 0.1 ml |
RA0082-C.5 | Carcinoembryonic Antigen (CEA) / CD66; Clone COL-1 (Konsantre) | 0.5 ml |
RA0085-C.1 | Carcinoembryonic Antigen (CEA) / CD66; Clone COL-1, CEA31 & C66/261 (Konsantre) | 0.1 ml |
RA0085-C.5 | Carcinoembryonic Antigen (CEA) / CD66; Clone COL-1, CEA31 & C66/261 (Konsantre) | 0.5 ml |
RA0486-C.1 | Carcinoembryonic Antigen (CEA) / CD66; Clone SPM330 (Konsantre) | 0.1 ml |
RA0486-C.5 | Carcinoembryonic Antigen (CEA) / CD66; Clone SPM330 (Konsantre) | 0.5 ml |
RA0486-C1 | Carcinoembryonic Antigen (CEA) / CD66; Clone SPM330 (Konsantre) | 1 ml |
RA0487-C.1 | Carcinoembryonic Antigen (CEA) / CD66; Clone SPM551 (Konsantre) | 0.1 ml |
RA0487-C.5 | Carcinoembryonic Antigen (CEA) / CD66; Clone SPM551 (Konsantre) | 0.5 ml |
RA0487-C1 | Carcinoembryonic Antigen (CEA) / CD66; Clone SPM551 (Konsantre) | 1 ml |
RA0484-C.1 | Carcinoembryonic Antigen (CEA) / CD66; Clone SPM584 (Konsantre) | 0.1 ml |
RA0484-C.5 | Carcinoembryonic Antigen (CEA) / CD66; Clone SPM584 (Konsantre) | 0.5 ml |
RA0484-C1 | Carcinoembryonic Antigen (CEA) / CD66; Clone SPM584 (Konsantre) | 1 ml |
RA0491-C.1 | Carcinoembryonic Antigen, pan (CEA) / CD66; Clone Cocktail (Konsantre) | 0.1 ml |
ARAŞTIRMA ANTİKORLARI RUO | DİLÜSYON ORANLARI | |
---|---|---|
RA0491-C.5 | Carcinoembryonic Antigen, pan (CEA) / CD66; Clone Cocktail (Konsantre) | 0.5 ml |
RA0491-C1 | Carcinoembryonic Antigen, pan (CEA) / CD66; Clone Cocktail (Konsantre) | 1 ml |
RA0461-C.1 | CD10 (Membrane Metalloendopeptidase); Clone 56C6 (Konsantre) | 0.1 ml |
RA0461-C.5 | CD10 (Membrane Metalloendopeptidase); Clone 56C6 (Konsantre) | 0.5 ml |
RA0461-C1 | CD10 (Membrane Metalloendopeptidase); Clone 56C6 (Konsantre) | 1 ml |
RA0492-C.1 | CD100 (Semaphorin-4D); Clone 133-1C6 (Konsantre) | 0.1 ml |
RA0492-C.5 | CD100 (Semaphorin-4D); Clone 133-1C6 (Konsantre) | 0.5 ml |
RA0492-C1 | CD100 (Semaphorin-4D); Clone 133-1C6 (Konsantre) | 1 ml |
RA0493-C.1 | CD100 (Semaphorin-4D); Clone A8 (Konsantre) | 0.1 ml |
RA0493-C.5 | CD100 (Semaphorin-4D); Clone A8 (Konsantre) | 0.5 ml |
RA0493-C1 | CD100 (Semaphorin-4D); Clone A8 (Konsantre) | 1 ml |
RA0335-C.1 | CD106 / VCAM1 (Activated Endothelial Cell Marker); Clone 1.4C3 (Konsantre) | 0.1 ml |
RA0335-C.5 | CD106 / VCAM1 (Activated Endothelial Cell Marker); Clone 1.4C3 (Konsantre) | 0.5 ml |
RA0336-C.1 | CD106 / VCAM1 (Activated Endothelial Cell Marker); Clone VCAM1/843 (Konsantre) | 0.1 ml |
RA0336-C.5 | CD106 / VCAM1 (Activated Endothelial Cell Marker); Clone VCAM1/843 (Konsantre) | 0.5 ml |
RA0168-C.1 | CD117/c-Kit (Marker for Gastrointestinal Stromal Tumors); Clone C117/370 (Konsantre) | 0.1 ml |
RA0168-C.5 | CD117/c-Kit (Marker for Gastrointestinal Stromal Tumors); Clone C117/370 (Konsantre) | 0.5 ml |
RA0428-C.1 | CD147 / EMMPRIN / Basigin (BSG); Clone BSG/963 (Konsantre) | 0.1 ml |
RA0428-C.5 | CD147 / EMMPRIN / Basigin (BSG); Clone BSG/963 (Konsantre) | 0.5 ml |
RA0428-C1 | CD147 / EMMPRIN / Basigin (BSG); Clone BSG/963 (Konsantre) | 1 ml |
RA0120-C.1 | CD15 / FUT4 (Reed-Sternberg Cell Marker); Clone FUT4/815 (Konsantre) | 0.1 ml |
RA0120-C.5 | CD15 / FUT4 (Reed-Sternberg Cell Marker); Clone FUT4/815 (Konsantre) | 0.5 ml |
RA0119-C.1 | CD15 / FUT4 (Reed-Sternberg Cell Marker); Clone Leu-M1 (MMA) (Konsantre) | 0.1 ml |
RA0119-C.5 | CD15 / FUT4 (Reed-Sternberg Cell Marker); Clone Leu-M1 (MMA) (Konsantre) | 0.5 ml |
RA0119-C1 | CD15 / FUT4 (Reed-Sternberg Cell Marker); Clone Leu-M1 (MMA) (Konsantre) | 1 ml |
RA0032-C.1 | CD1a / HTA1 (Mature Langerhans Cells Marker); Clone C1A/711 (Konsantre) | 0.1 ml |
RA0032-C.5 | CD1a / HTA1 (Mature Langerhans Cells Marker); Clone C1A/711 (Konsantre) | 0.5 ml |
RA0031-C.1 | CD1a / HTA1 (Mature Langerhans Cells Marker); Clone O10 (Konsantre) | 0.1 ml |
RA0031-C.5 | CD1a / HTA1 (Mature Langerhans Cells Marker); Clone O10 (Konsantre) | 0.5 ml |
RA0033-C.1 | CD1a / HTA1 (Mature Langerhans Cells Marker); Clone O10 & C1A/711 (Konsantre) | 0.1 ml |
RA0033-C.5 | CD1a / HTA1 (Mature Langerhans Cells Marker); Clone O10 & C1A/711 (Konsantre) | 0.5 ml |
RA0046-C.1 | CD20 / MS4A1 (B-Cell Marker); Clone IGEL/773 (Konsantre) | 0.1 ml |
RA0046-C.5 | CD20 / MS4A1 (B-Cell Marker); Clone IGEL/773 (Konsantre) | 0.5 ml |
RA0045-C.1 | CD20 / MS4A1 (B-Cell Marker); Clone L26 (Konsantre) | 0.1 ml |
RA0045-C.5 | CD20 / MS4A1 (B-Cell Marker); Clone L26 (Konsantre) | 0.5 ml |
RA0047-C.1 | CD20 / MS4A1 (B-Cell Marker); Clone L26 & IGEL/773 (Konsantre) | 0.1 ml |
RA0047-C.5 | CD20 / MS4A1 (B-Cell Marker); Clone L26 & IGEL/773 (Konsantre) | 0.5 ml |
RA0049-C.1 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone Ber-H2 (Konsantre) | 0.1 ml |
RA0049-C.5 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone Ber-H2 (Konsantre) | 0.5 ml |
RA0049-C1 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone Ber-H2 (Konsantre) | 1 ml |
RA0051-C.1 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone Ber-H2 & CD30/412 (Konsantre) | 0.1 ml |
RA0051-C.5 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone Ber-H2 & CD30/412 (Konsantre) | 0.5 ml |
RA0048-C.1 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone CD30/412 (Konsantre) | 0.1 ml |
RA0048-C.5 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone CD30/412 (Konsantre) | 0.5 ml |
RA0050-C.1 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone Ki-1/779 (Konsantre) | 0.1 ml |
RA0050-C.5 | CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker); Clone Ki-1/779 (Konsantre) | 0.5 ml |
RA0262-C.1 | CD31 / PECAM-1 (Endothelial Cell Marker); Clone 158-2B3 (Konsantre) | 0.1 ml |
RA0262-C.5 | CD31 / PECAM-1 (Endothelial Cell Marker); Clone 158-2B3 (Konsantre) | 0.5 ml |
RA0260-C.1 | CD31 / PECAM-1 (Endothelial Cell Marker); Clone 1A10 (Konsantre) | 0.1 ml |
RA0260-C.5 | CD31 / PECAM-1 (Endothelial Cell Marker); Clone 1A10 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | DİLÜSYON ORANLARI | |
---|---|---|
RA0257-C.1 | CD31 / PECAM-1 (Endothelial Cell Marker); Clone C31.3 (Konsantre) | 0.1 ml |
RA0257-C.5 | CD31 / PECAM-1 (Endothelial Cell Marker); Clone C31.3 (Konsantre) | 0.5 ml |
RA0258-C.1 | CD31 / PECAM-1 (Endothelial Cell Marker); Clone C31.3 & JC/70A (Konsantre) | 0.1 ml |
RA0258-C.5 | CD31 / PECAM-1 (Endothelial Cell Marker); Clone C31.3 & JC/70A (Konsantre) | 0.5 ml |
RA0256-C.1 | CD31 / PECAM-1 (Endothelial Cell Marker); Clone C31.7 (Konsantre) | 0.1 ml |
RA0256-C.5 | CD31 / PECAM-1 (Endothelial Cell Marker); Clone C31.7 (Konsantre) | 0.5 ml |
RA0259-C.1 | CD31 / PECAM-1 (Endothelial Cell Marker); Clone JC/70A (Konsantre) | 0.1 ml |
RA0259-C.5 | CD31 / PECAM-1 (Endothelial Cell Marker); Clone JC/70A (Konsantre) | 0.5 ml |
RA0261-C.1 | CD31 / PECAM-1 (Endothelial Cell Marker); Clone PECA1/848 (Konsantre) | 0.1 ml |
RA0261-C.5 | CD31 / PECAM-1 (Endothelial Cell Marker); Clone PECA1/848 (Konsantre) | 0.5 ml |
RA0053-C.1 | CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone HPCA1/763 (Konsantre) | 0.1 ml |
RA0053-C.5 | CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone HPCA1/763 (Konsantre) | 0.5 ml |
RA0052-C.1 | CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone QBEnd/10 (Konsantre) | 0.1 ml |
RA0052-C.5 | CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone QBEnd/10 (Konsantre) | 0.5 ml |
RA0054-C.1 | CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone QBEnd/10 & HPCA1/763 (Konsantre) | 0.1 ml |
RA0054-C.5 | CD34 (Hematopoietic Stem Cell & Endothelial Marker); Clone QBEnd/10 & HPCA1/763 (Konsantre) | 0.5 ml |
RA0103-C.1 | CD35 / CR1 (Follicular Dendritic Cell Marker); Clone CR1/802 (Konsantre) | 0.1 ml |
RA0103-C.5 | CD35 / CR1 (Follicular Dendritic Cell Marker); Clone CR1/802 (Konsantre) | 0.5 ml |
RA0102-C.1 | CD35 / CR1 (Follicular Dendritic Cell Marker); Clone E11 (Konsantre) | 0.1 ml |
RA0102-C.5 | CD35 / CR1 (Follicular Dendritic Cell Marker); Clone E11 (Konsantre) | 0.5 ml |
RA0299-C.1 | CD43 (T-Cell Marker); Clone 84-3C1 (Konsantre) | 0.1 ml |
RA0299-C.5 | CD43 (T-Cell Marker); Clone 84-3C1 (Konsantre) | 0.5 ml |
RA0297-C.1 | CD43 (T-Cell Marker); Clone DF-T1 (Konsantre) | 0.1 ml |
RA0297-C.5 | CD43 (T-Cell Marker); Clone DF-T1 (Konsantre) | 0.5 ml |
RA0298-C.1 | CD43 (T-Cell Marker); Clone SPN/839 (Konsantre) | 0.1 ml |
RA0298-C.5 | CD43 (T-Cell Marker); Clone SPN/839 (Konsantre) | 0.5 ml |
RA0055-C.1 | CD44 / HCAM Std.; Clone 156-3C11 (Konsantre) | 0.1 ml |
RA0055-C.5 | CD44 / HCAM Std.; Clone 156-3C11 (Konsantre) | 0.5 ml |
RA0055-C1 | CD44 / HCAM Std.; Clone 156-3C11 (Konsantre) | 1 ml |
RA0056-C.1 | CD44 / HCAM Std.; Clone HCAM/918 (Konsantre) | 0.1 ml |
RA0056-C.5 | CD44 / HCAM Std.; Clone HCAM/918 (Konsantre) | 0.5 ml |
RA0283-C.1 | CD45 / LCA (Leukocyte Marker); Clone 135-4C5 (Konsantre) | 0.1 ml |
RA0283-C.5 | CD45 / LCA (Leukocyte Marker); Clone 135-4C5 (Konsantre) | 0.5 ml |
RA0284-C.1 | CD45 / LCA (Leukocyte Marker); Clone 136-4B5 (Konsantre) | 0.1 ml |
RA0284-C.5 | CD45 / LCA (Leukocyte Marker); Clone 136-4B5 (Konsantre) | 0.5 ml |
RA0277-C.1 | CD45 / LCA (Leukocyte Marker); Clone 2B11 (Konsantre) | 0.1 ml |
RA0277-C.5 | CD45 / LCA (Leukocyte Marker); Clone 2B11 (Konsantre) | 0.5 ml |
RA0280-C.1 | CD45 / LCA (Leukocyte Marker); Clone 2B11 & PD7/26 (Konsantre) | 0.1 ml |
RA0280-C.5 | CD45 / LCA (Leukocyte Marker); Clone 2B11 & PD7/26 (Konsantre) | 0.5 ml |
RA0282-C.1 | CD45RA (Leukocyte Marker); Clone 111-1C5 (Konsantre) | 0.1 ml |
RA0282-C.5 | CD45RA (Leukocyte Marker); Clone 111-1C5 (Konsantre) | 0.5 ml |
RA0275-C.1 | CD45RA (Leukocyte Marker); Clone 158-4D3 (Konsantre) | 0.1 ml |
RA0275-C.5 | CD45RA (Leukocyte Marker); Clone 158-4D3 (Konsantre) | 0.5 ml |
RA0279-C.1 | CD45RB (Leukocyte Marker); Clone PD7/26 (Konsantre) | 0.1 ml |
RA0279-C.5 | CD45RB (Leukocyte Marker); Clone PD7/26 (Konsantre) | 0.5 ml |
RA0281-C.1 | CD45RO (T-Cell Marker); Clone T200/797 (Konsantre) | 0.1 ml |
RA0281-C.5 | CD45RO (T-Cell Marker); Clone T200/797 (Konsantre) | 0.5 ml |
RA0274-C.1 | CD45RO (T-Cell Marker); Clone UCHL-1 (Konsantre) | 0.1 ml |
RA0274-C.5 | CD45RO (T-Cell Marker); Clone UCHL-1 (Konsantre) | 0.5 ml |
RA0034-C.1 | CD5 (Mantle Cell Lymphoma Marker); Clone C5/473 (Konsantre) | 0.1 ml |
ARAŞTIRMA ANTİKORLARI RUO | DİLÜSYON ORANLARI | |
---|---|---|
RA0034-C.5 | CD5 (Mantle Cell Lymphoma Marker); Clone C5/473 (Konsantre) | 0.5 ml |
RA0037-C.1 | CD5 (Mantle Cell Lymphoma Marker); Clone C5/473 & CD5/54/F6 (Konsantre) | 0.1 ml |
RA0037-C.5 | CD5 (Mantle Cell Lymphoma Marker); Clone C5/473 & CD5/54/F6 (Konsantre) | 0.5 ml |
RA0036-C.1 | CD5 (Mantle Cell Lymphoma Marker); Clone CD5/54/F6 (Konsantre) | 0.1 ml |
RA0036-C.5 | CD5 (Mantle Cell Lymphoma Marker); Clone CD5/54/F6 (Konsantre) | 0.5 ml |
RA0440-C.1 | CD50 / ICAM3; Clone ICAM3/1019 (Konsantre) | 0.1 ml |
RA0440-C.5 | CD50 / ICAM3; Clone ICAM3/1019 (Konsantre) | 0.5 ml |
RA0440-C1 | CD50 / ICAM3; Clone ICAM3/1019 (Konsantre) | 1 ml |
RA0238-C.1 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone 123A8 (56C04) (Konsantre) | 0.1 ml |
RA0238-C.5 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone 123A8 (56C04) (Konsantre) | 0.5 ml |
RA0237-C.1 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone 123C3.D5 (Konsantre) | 0.1 ml |
RA0237-C.5 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone 123C3.D5 (Konsantre) | 0.5 ml |
RA0239-C.1 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone 123C3.D5 & 123A8 (Konsantre) | 0.1 ml |
RA0239-C.5 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone 123C3.D5 & 123A8 (Konsantre) | 0.5 ml |
RA0240-C.1 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone NKH1/784 (Konsantre) | 0.1 ml |
RA0240-C.5 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone NKH1/784 (Konsantre) | 0.5 ml |
RA0241-C.1 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone NKH1/795 (Konsantre) | 0.1 ml |
RA0241-C.5 | CD56 / NCAM1 / NKH1 (Neuronal Cell Marker); Clone NKH1/795 (Konsantre) | 0.5 ml |
RA0357-C.1 | CD57 / B3GAT1 (Natural Killer Cell Marker); Clone HNK-1 & NK-1 (Konsantre) | 0.1 ml |
RA0357-C.5 | CD57 / B3GAT1 (Natural Killer Cell Marker); Clone HNK-1 & NK-1 (Konsantre) | 0.5 ml |
RA0355-C.1 | CD57 / B3GAT1 (Natural Killer Cell Marker); Clone HNK-1 or Leu-7 (Konsantre) | 0.1 ml |
RA0355-C.5 | CD57 / B3GAT1 (Natural Killer Cell Marker); Clone HNK-1 or Leu-7 (Konsantre) | 0.5 ml |
RA0358-C.1 | CD57 / B3GAT1 (Natural Killer Cell Marker); Clone NK/804 (Konsantre) | 0.1 ml |
RA0358-C.5 | CD57 / B3GAT1 (Natural Killer Cell Marker); Clone NK/804 (Konsantre) | 0.5 ml |
RA0356-C.1 | CD57 / B3GAT1 (Natural Killer Cell Marker); Clone NK-1 (Konsantre) | 0.1 ml |
RA0356-C.5 | CD57 / B3GAT1 (Natural Killer Cell Marker); Clone NK-1 (Konsantre) | 0.5 ml |
RA0038-C.1 | CD6; Clone 3F7B5 (Konsantre) | 0.1 ml |
RA0038-C.5 | CD6; Clone 3F7B5 (Konsantre) | 0.5 ml |
RA0039-C.1 | CD6; Clone C6/372 (Konsantre) | 0.1 ml |
RA0039-C.5 | CD6; Clone C6/372 (Konsantre) | 0.5 ml |
RA0040-C.1 | CD6; Clone C6/372 & 3F7B5 (Konsantre) | 0.1 ml |
RA0040-C.5 | CD6; Clone C6/372 & 3F7B5 (Konsantre) | 0.5 ml |
RA0059-C.1 | CD63 (Late Endosomes Marker); Clone LAMP3/803 (Konsantre) | 0.1 ml |
RA0059-C.5 | CD63 (Late Endosomes Marker); Clone LAMP3/803 (Konsantre) | 0.5 ml |
RA0058-C.1 | CD63 (Late Endosomes Marker); Clone MX-49.129.5 (Konsantre) | 0.1 ml |
RA0058-C.5 | CD63 (Late Endosomes Marker); Clone MX-49.129.5 (Konsantre) | 0.5 ml |
RA0057-C.1 | CD63 (Late Endosomes Marker); Clone NKI/C3 (Konsantre) | 0.1 ml |
RA0057-C.5 | CD63 (Late Endosomes Marker); Clone NKI/C3 (Konsantre) | 0.5 ml |
RA0061-C.1 | CD68 (Macrophage Marker); Clone C68/684 (Konsantre) | 0.1 ml |
RA0061-C.5 | CD68 (Macrophage Marker); Clone C68/684 (Konsantre) | 0.5 ml |
RA0064-C.1 | CD68 (Macrophage Marker); Clone CD68/G2 (Konsantre) | 0.1 ml |
RA0064-C.5 | CD68 (Macrophage Marker); Clone CD68/G2 (Konsantre) | 0.5 ml |
RA0060-C.1 | CD68 (Macrophage Marker); Clone KP1 (Konsantre) | 0.1 ml |
RA0060-C.5 | CD68 (Macrophage Marker); Clone KP1 (Konsantre) | 0.5 ml |
RA0062-C.1 | CD68 (Macrophage Marker); Clone KP1 & C68/684 (Konsantre) | 0.1 ml |
RA0062-C.5 | CD68 (Macrophage Marker); Clone KP1 & C68/684 (Konsantre) | 0.5 ml |
RA0063-C.1 | CD68 (Macrophage Marker); Clone LAMP4/824 (Konsantre) | 0.1 ml |
RA0063-C.5 | CD68 (Macrophage Marker); Clone LAMP4/824 (Konsantre) | 0.5 ml |
RA0066-C.1 | CD74 (B-Cell Marker); Clone CLIP/813 (Konsantre) | 0.1 ml |
RA0066-C.5 | CD74 (B-Cell Marker); Clone CLIP/813 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | DİLÜSYON ORANLARI | ||
---|---|---|---|
RA0065-C.1 | CD74 (B-Cell Marker); Clone LN-2 (Konsantre) | 0.1 ml | |
RA0065-C.5 | CD74 (B-Cell Marker); Clone LN-2 (Konsantre) | 0.5 ml | |
RA0069-C.1 | CD79a (B-Cell Marker); Clone HM47/A9 (Konsantre) | 0.1 ml | |
RA0069-C.5 | CD79a (B-Cell Marker); Clone HM47/A9 (Konsantre) | 0.5 ml | |
RA0073-C.1 | CD79a (B-Cell Marker); Clone IGA/515 (Konsantre) | 0.1 ml | |
RA0073-C.5 | CD79a (B-Cell Marker); Clone IGA/515 (Konsantre) | 0.5 ml | |
RA0072-C.1 | CD79a (B-Cell Marker); Clone IGA/764 (Konsantre) | 0.1 ml | |
RA0072-C.5 | CD79a (B-Cell Marker); Clone IGA/764 (Konsantre) | 0.5 ml | |
RA0067-C.1 | CD79a (B-Cell Marker); Clone JCB117 (Konsantre) | 0.1 ml | |
RA0067-C.5 | CD79a (B-Cell Marker); Clone JCB117 (Konsantre) | 0.5 ml | |
RA0071-C.1 | CD79a (B-Cell Marker); Clone JCB117 & HM47/A9 (Konsantre) | 0.1 ml | |
RA0071-C.5 | CD79a (B-Cell Marker); Clone JCB117 & HM47/A9 (Konsantre) | 0.5 ml | |
RA0042-C.1 | CD8A (Cytotoxic & Suppressor T-Cell Marker); Clone C8/144B (Konsantre) | 0.1 ml | |
RA0042-C.5 | CD8A (Cytotoxic & Suppressor T-Cell Marker); Clone C8/144B (Konsantre) | 0.5 ml | |
RA0041-C.1 | CD8A (Cytotoxic & Suppressor T-Cell Marker); Clone C8/468 (Konsantre) | 0.1 ml | |
RA0041-C.5 | CD8A (Cytotoxic & Suppressor T-Cell Marker); Clone C8/468 (Konsantre) | 0.5 ml | |
RA0043-C.1 | CD8A (Cytotoxic & Suppressor T-Cell Marker); Clone C8/468 & C8/144B (Konsantre) | 0.1 ml | |
RA0043-C.5 | CD8A (Cytotoxic & Suppressor T-Cell Marker); Clone C8/468 & C8/144B (Konsantre) | 0.5 ml | |
RA0044-C.1 | CD8A (Cytotoxic & Suppressor T-Cell Marker); Rabbit Polyclonal (Konsantre) | 0.1 ml | |
RA0044-C.5 | CD8A (Cytotoxic & Suppressor T-Cell Marker); Rabbit Polyclonal (Konsantre) | 0.5 ml | |
RA0204-C.1 | CD99 / MIC2 (Ewing's Sarcoma Marker); Clone 12E7 (Konsantre) | 0.1 ml | |
RA0204-C.5 | CD99 / MIC2 (Ewing's Sarcoma Marker); Clone 12E7 (Konsantre) | 0.5 ml | |
RA0206-C.1 | CD99 / MIC2 (Ewing's Sarcoma Marker); Clone 12E7 & MIC2/877 (Konsantre) | 0.1 ml | |
RA0206-C.5 | CD99 / MIC2 (Ewing's Sarcoma Marker); Clone 12E7 & MIC2/877 (Konsantre) | 0.5 ml | |
RA0203-C.1 | CD99 / MIC2 (Ewing's Sarcoma Marker); Clone HO36-1.1 (Konsantre) | 0.1 ml | |
RA0203-C.5 | CD99 / MIC2 (Ewing's Sarcoma Marker); Clone HO36-1.1 (Konsantre) | 0.5 ml | |
RA0205-C.1 | CD99 / MIC2 (Ewing's Sarcoma Marker); Clone MIC2/877 (Konsantre) | 0.1 ml | |
RA0205-C.5 | CD99 / MIC2 (Ewing's Sarcoma Marker); Clone MIC2/877 (Konsantre) | 0.5 ml | |
RA0291-C.1 | CDw75 (B-Cell Marker); Clone LN-1 (Konsantre) | 0.1 ml | |
RA0291-C.5 | CDw75 (B-Cell Marker); Clone LN-1 (Konsantre) | 0.5 ml | |
RA0291-C1 | CDw75 (B-Cell Marker); Clone LN-1 (Konsantre) | 1 ml | |
RA0480-C.1 | CDX2 (GI Epithelial Marker); Clone CDX2/1690 (Konsantre) | 0.1 ml | |
RA0480-C.5 | CDX2 (GI Epithelial Marker); Clone CDX2/1690 (Konsantre) | 0.5 ml | |
RA0480-C1 | CDX2 (GI Epithelial Marker); Clone CDX2/1690 (Konsantre) | 1 ml | |
RA0497-C.1 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone CFTR/1341 (Konsantre) | 0.1 ml | |
RA0497-C.5 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone CFTR/1341 (Konsantre) | 0.5 ml | |
RA0497-C1 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone CFTR/1341 (Konsantre) | 1 ml | |
RA0498-C.1 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone CFTR/1342 (Konsantre) | 0.1 ml | |
RA0498-C.5 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone CFTR/1342 (Konsantre) | 0.5 ml | |
RA0498-C1 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone CFTR/1342 (Konsantre) | 1 ml | |
RA0500-C.1 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone CFTR/1643 (Konsantre) | 0.1 ml | |
RA0500-C.5 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone CFTR/1643 (Konsantre) | 0.5 ml | |
RA0500-C1 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone CFTR/1643 (Konsantre) | 1 ml | |
RA0503-C.1 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone CFTR/1775R (Konsantre) | 0.1 ml | |
RA0503-C.5 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone CFTR/1775R (Konsantre) | 0.5 ml | |
RA0503-C1 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone CFTR/1775R (Konsantre) | 1 ml | |
RA0502-C.1 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone CFTR/1785 (Konsantre) | 0.1 ml | |
RA0502-C.5 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone CFTR/1785 (Konsantre) | 0.5 ml | |
RA0502-C1 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone CFTR/1785 (Konsantre) | 1 ml | |
RA0499-C.1 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone SPM176 (Konsantre) | 0.1 ml |
ARAŞTIRMA ANTİKORLARI RUO | DİLÜSYON ORANLARI | |
---|---|---|
RA0499-C.5 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone SPM176 (Konsantre) | 0.5 ml |
RA0499-C1 | CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); Clone SPM176 (Konsantre) | 1 ml |
RA0514-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CGA/413 (Konsantre) | 0.1 ml |
RA0514-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CGA/413 (Konsantre) | 0.5 ml |
RA0514-C1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CGA/413 (Konsantre) | 1 ml |
RA0090-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CGA/414 (Konsantre) | 0.1 ml |
RA0090-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CGA/414 (Konsantre) | 0.5 ml |
RA0516-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/1773R (Konsantre) | 0.1 ml |
RA0516-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/1773R (Konsantre) | 0.5 ml |
RA0516-C1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/1773R (Konsantre) | 1 ml |
RA0517-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/1815R (Konsantre) | 0.1 ml |
RA0517-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/1815R (Konsantre) | 0.5 ml |
RA0517-C1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/1815R (Konsantre) | 1 ml |
RA0096-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/765 (Konsantre) | 0.1 ml |
RA0096-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/765 (Konsantre) | 0.5 ml |
RA0097-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/777 (Konsantre) | 0.1 ml |
RA0097-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/777 (Konsantre) | 0.5 ml |
RA0098-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/798 (Konsantre) | 0.1 ml |
RA0098-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone CHGA/798 (Konsantre) | 0.5 ml |
RA0091-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone LK2H10 (Konsantre) | 0.1 ml |
RA0091-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone LK2H10 (Konsantre) | 0.5 ml |
RA0094-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone LK2H10 & PHE5 (Konsantre) | 0.1 ml |
RA0094-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone LK2H10 & PHE5 (Konsantre) | 0.5 ml |
RA0095-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone LK2H10, PHE5 & CGA/414 (Konsantre) | 0.1 ml |
RA0095-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone LK2H10, PHE5 & CGA/414 (Konsantre) | 0.5 ml |
RA0095-C1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone LK2H10, PHE5 & CGA/414 (Konsantre) | 1 ml |
RA0093-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone PHE5 (Konsantre) | 0.1 ml |
RA0093-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone PHE5 (Konsantre) | 0.5 ml |
RA0512-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone SPM339 (Konsantre) | 0.1 ml |
RA0512-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone SPM339 (Konsantre) | 0.5 ml |
RA0512-C1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone SPM339 (Konsantre) | 1 ml |
RA0511-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone SPM553 (Konsantre) | 0.1 ml |
RA0511-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone SPM553 (Konsantre) | 0.5 ml |
RA0511-C1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone SPM553 (Konsantre) | 1 ml |
RA0513-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone SPM585 (Konsantre) | 0.1 ml |
RA0513-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone SPM585 (Konsantre) | 0.5 ml |
RA0513-C1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clone SPM585 (Konsantre) | 1 ml |
RA0510-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clones CGA/413 & CHGA/777 & CHGA/798 (Konsantre) | 0.1 ml |
RA0510-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Clones CGA/413 & CHGA/777 & CHGA/798 (Konsantre) | 0.5 ml |
RA0510-C1 | Chromogranin A / CHGA (Neuroendocrine Marker); Clones CGA/413 & CHGA/777 & CHGA/798 (Konsantre) | 1 ml |
RA0518-C.1 | Chromogranin A / CHGA (Neuroendocrine Marker); Polyclonal (Konsantre) | 0.1 ml |
RA0518-C.5 | Chromogranin A / CHGA (Neuroendocrine Marker); Polyclonal (Konsantre) | 0.5 ml |
RA0518-C1 | Chromogranin A / CHGA (Neuroendocrine Marker); Polyclonal (Konsantre) | 1 ml |
RA0524-C.1 | Clathrin, Light Chain; Clone CLC/1421 (Konsantre) | 0.1 ml |
RA0524-C.5 | Clathrin, Light Chain; Clone CLC/1421 (Konsantre) | 0.5 ml |
RA0524-C1 | Clathrin, Light Chain; Clone CLC/1421 (Konsantre) | 1 ml |
RA0226-C.1 | c-Myc Oncoprotein; Clone 9E10.3 (Konsantre) | 0.1 ml |
RA0226-C.5 | c-Myc Oncoprotein; Clone 9E10.3 (Konsantre) | 0.5 ml |
RA0227-C.1 | c-Myc Oncoprotein; Clone MYC909 (Konsantre) | 0.1 ml |
RA0227-C.5 | c-Myc Oncoprotein; Clone MYC909 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | DİLÜSYON ORANLARI | |
---|---|---|
RA0025-C.1 | Complement 4d (C4d) (Acute Humoral Rejection Marker); Clone C4D204 (Konsantre) | 0.1 ml |
RA0025-C.5 | Complement 4d (C4d) (Acute Humoral Rejection Marker); Clone C4D204 (Konsantre) | 0.5 ml |
RA0434-C.1 | CPS1 / Carbamoyl-Phosphate Synthetase (Hepatic Mitochondrial Marker); Clone CPS1/1022 (Konsantre) | 0.1 ml |
RA0434-C.5 | CPS1 / Carbamoyl-Phosphate Synthetase (Hepatic Mitochondrial Marker); Clone CPS1/1022 (Konsantre) | 0.5 ml |
RA0434-C1 | CPS1 / Carbamoyl-Phosphate Synthetase (Hepatic Mitochondrial Marker); Clone CPS1/1022 (Konsantre) | 1 ml |
RA0519-C.1 | Creatine Kinase-BB (CK-BB); Clone 2ba6 (Konsantre) | 0.1 ml |
RA0519-C.5 | Creatine Kinase-BB (CK-BB); Clone 2ba6 (Konsantre) | 0.5 ml |
RA0519-C1 | Creatine Kinase-BB (CK-BB); Clone 2ba6 (Konsantre) | 1 ml |
RA0429-C.5 | Cyclin B1 (G2- & M-phase Cyclin); Clone CCNB1/1098 (Konsantre) | 0.5 ml |
RA0426-C.1 | Cyclin D1 (G1-Cyclin & Mantle Cell Marker); Clone CCND1/809 (Konsantre) | 0.1 ml |
RA0426-C.5 | Cyclin D1 (G1-Cyclin & Mantle Cell Marker); Clone CCND1/809 (Konsantre) | 0.5 ml |
RA0426-C1 | Cyclin D1 (G1-Cyclin & Mantle Cell Marker); Clone CCND1/809 (Konsantre) | 1 ml |
RA0014-C.1 | Cyclin D1 (G1-Cyclin & Mantle Cell Marker); Clone DCS-6 (Konsantre) | 0.1 ml |
RA0014-C.5 | Cyclin D1 (G1-Cyclin & Mantle Cell Marker); Clone DCS-6 (Konsantre) | 0.5 ml |
RA0359-C.1 | Cytochrome c (Mitochondrial Marker); Clone 7H8.2C12 (Konsantre) | 0.1 ml |
RA0359-C.5 | Cytochrome c (Mitochondrial Marker); Clone 7H8.2C12 (Konsantre) | 0.5 ml |
RA0360-C.1 | Cytochrome c (Mitochondrial Marker); Clone CTC05 (Konsantre) | 0.1 ml |
RA0360-C.5 | Cytochrome c (Mitochondrial Marker); Clone CTC05 (Konsantre) | 0.5 ml |
RA0179-C.1 | Cytokeratin 10 (Suprabasal Epithelial Marker); Clone AE20 (Konsantre) | 0.1 ml |
RA0179-C.5 | Cytokeratin 10 (Suprabasal Epithelial Marker); Clone AE20 (Konsantre) | 0.5 ml |
RA0460-C.1 | Cytokeratin 10 (Suprabasal Epithelial Marker); Clone DE-K10 (Konsantre) | 0.1 ml |
RA0460-C.5 | Cytokeratin 10 (Suprabasal Epithelial Marker); Clone DE-K10 (Konsantre) | 0.5 ml |
RA0460-C1 | Cytokeratin 10 (Suprabasal Epithelial Marker); Clone DE-K10 (Konsantre) | 1 ml |
RA0180-C.1 | Cytokeratin 10 (Suprabasal Epithelial Marker); Clone KRT10/844 (Konsantre) | 0.1 ml |
RA0180-C.5 | Cytokeratin 10 (Suprabasal Epithelial Marker); Clone KRT10/844 (Konsantre) | 0.5 ml |
RA0181-C.1 | Cytokeratin 14 (KRT14) (Squamous Cell Marker); Clone LL002 (Konsantre) | 0.1 ml |
RA0181-C.5 | Cytokeratin 14 (KRT14) (Squamous Cell Marker); Clone LL002 (Konsantre) | 0.5 ml |
RA0182-C.1 | Cytokeratin 17 (KRT17) (Basal Epithelial Marker); Clone E3 (Ks17.E3) (Konsantre) | 0.1 ml |
RA0182-C.5 | Cytokeratin 17 (KRT17) (Basal Epithelial Marker); Clone E3 (Ks17.E3) (Konsantre) | 0.5 ml |
RA0183-C.1 | Cytokeratin 17 (KRT17) (Basal Epithelial Marker); Clone KRT17/778 (Konsantre) | 0.1 ml |
RA0183-C.5 | Cytokeratin 17 (KRT17) (Basal Epithelial Marker); Clone KRT17/778 (Konsantre) | 0.5 ml |
RA0185-C.1 | Cytokeratin 18 (KRT18); Clone DA7 (Konsantre) | 0.1 ml |
RA0185-C.5 | Cytokeratin 18 (KRT18); Clone DA7 (Konsantre) | 0.5 ml |
RA0184-C.1 | Cytokeratin 18 (KRT18); Clone DC10 (Konsantre) | 0.1 ml |
RA0184-C.5 | Cytokeratin 18 (KRT18); Clone DC10 (Konsantre) | 0.5 ml |
RA0186-C.1 | Cytokeratin 18 (KRT18); Clone DE-K18 (Konsantre) | 0.1 ml |
RA0186-C.5 | Cytokeratin 18 (KRT18); Clone DE-K18 (Konsantre) | 0.5 ml |
RA0187-C.1 | Cytokeratin 18 (KRT18); Clone KRT18/834 (Konsantre) | 0.1 ml |
RA0187-C.5 | Cytokeratin 18 (KRT18); Clone KRT18/834 (Konsantre) | 0.5 ml |
RA0188-C.1 | Cytokeratin 18 (KRT18); Clone KRT18/835 (Konsantre) | 0.1 ml |
RA0188-C.5 | Cytokeratin 18 (KRT18); Clone KRT18/835 (Konsantre) | 0.5 ml |
RA0189-C.1 | Cytokeratin 18 (KRT18); Clone KRT18/836 (Konsantre) | 0.1 ml |
RA0189-C.5 | Cytokeratin 18 (KRT18); Clone KRT18/836 (Konsantre) | 0.5 ml |
RA0192-C.1 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone A53-B/A2.26 & BA17 (Konsantre) | 0.1 ml |
RA0192-C.5 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone A53-B/A2.26 & BA17 (Konsantre) | 0.5 ml |
RA0190-C.1 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone A53-B/A2.26 (Ks19.1) (Konsantre) | 0.1 ml |
RA0190-C.5 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone A53-B/A2.26 (Ks19.1) (Konsantre) | 0.5 ml |
RA0191-C.1 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone BA17 (Konsantre) | 0.1 ml |
RA0191-C.5 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone BA17 (Konsantre) | 0.5 ml |
RA0193-C.1 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone KRT19/799 (Konsantre) | 0.1 ml |
ARAŞTIRMA ANTİKORLARI RUO | DİLÜSYON ORANLARI | |
---|---|---|
RA0193-C.5 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone KRT19/799 (Konsantre) | 0.5 ml |
RA0194-C.1 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone KRT19/800 (Konsantre) | 0.1 ml |
RA0194-C.5 | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker); Clone KRT19/800 (Konsantre) | 0.5 ml |
RA0170-C.1 | Cytokeratin 7 (Glandular and Transitional Epithelial Marker); Clone K72.7 (Konsantre) | 0.1 ml |
RA0170-C.5 | Cytokeratin 7 (Glandular and Transitional Epithelial Marker); Clone K72.7 (Konsantre) | 0.5 ml |
RA0171-C.1 | Cytokeratin 7 (Glandular and Transitional Epithelial Marker); Clone KRT7/760 (Konsantre) | 0.1 ml |
RA0171-C.5 | Cytokeratin 7 (Glandular and Transitional Epithelial Marker); Clone KRT7/760 (Konsantre) | 0.5 ml |
RA0169-C.1 | Cytokeratin 7 (Glandular and Transitional Epithelial Marker); Clone OV-TL12/30 (Konsantre) | 0.1 ml |
RA0169-C.5 | Cytokeratin 7 (Glandular and Transitional Epithelial Marker); Clone OV-TL12/30 (Konsantre) | 0.5 ml |
RA0172-C.1 | Cytokeratin 7 (Glandular and Transitional Epithelial Marker); Clone OV-TL12/30 & K72.7 (Konsantre) | 0.1 ml |
RA0172-C.5 | Cytokeratin 7 (Glandular and Transitional Epithelial Marker); Clone OV-TL12/30 & K72.7 (Konsantre) | 0.5 ml |
RA0178-C.1 | Cytokeratin 8 (KRT8); Clone 34BH11 (Konsantre) | 0.1 ml |
RA0178-C.5 | Cytokeratin 8 (KRT8); Clone 34BH11 (Konsantre) | 0.5 ml |
RA0173-C.1 | Cytokeratin 8 (KRT8); Clone H1 (Konsantre) | 0.1 ml |
RA0173-C.5 | Cytokeratin 8 (KRT8); Clone H1 (Konsantre) | 0.5 ml |
RA0176-C.1 | Cytokeratin 8 (KRT8); Clone H1 & TS1 (Konsantre) | 0.1 ml |
RA0176-C.5 | Cytokeratin 8 (KRT8); Clone H1 & TS1 (Konsantre) | 0.5 ml |
RA0174-C.1 | Cytokeratin 8 (KRT8); Clone K8/383 (Konsantre) | 0.1 ml |
RA0174-C.5 | Cytokeratin 8 (KRT8); Clone K8/383 (Konsantre) | 0.5 ml |
RA0177-C.1 | Cytokeratin 8 (KRT8); Clone KRT8/818 (Konsantre) | 0.1 ml |
RA0177-C.5 | Cytokeratin 8 (KRT8); Clone KRT8/818 (Konsantre) | 0.5 ml |
RA0175-C.1 | Cytokeratin 8 (KRT8); Clone TS1 (Konsantre) | 0.1 ml |
RA0175-C.5 | Cytokeratin 8 (KRT8); Clone TS1 (Konsantre) | 0.5 ml |
RA0388-C.1 | Cytokeratin 8/18 (Epithelial Marker); Clone C-43 & DC10 (Konsantre) | 0.1 ml |
RA0388-C.5 | Cytokeratin 8/18 (Epithelial Marker); Clone C-43 & DC10 (Konsantre) | 0.5 ml |
RA0387-C.1 | Cytokeratin 8/18 (Epithelial Marker); Clone K8.8 & DC10 (Konsantre) | 0.1 ml |
RA0387-C.5 | Cytokeratin 8/18 (Epithelial Marker); Clone K8.8 & DC10 (Konsantre) | 0.5 ml |
RA0387-C1 | Cytokeratin 8/18 (Epithelial Marker); Clone K8.8 & DC10 (Konsantre) | 1 ml |
RA0441-C.1 | Cytokeratin 8; Clone KRT8/899 (Konsantre) | 0.1 ml |
RA0441-C.5 | Cytokeratin 8; Clone KRT8/899 (Konsantre) | 0.5 ml |
RA0441-C1 | Cytokeratin 8; Clone KRT8/899 (Konsantre) | 1 ml |
RA0385-C.1 | Cytokeratin, Acidic (Type I or LMW) (Epithelial Marker); Clone AE-1 (Konsantre) | 0.1 ml |
RA0385-C.5 | Cytokeratin, Acidic (Type I or LMW) (Epithelial Marker); Clone AE-1 (Konsantre) | 0.5 ml |
RA0389-C.1 | Cytokeratin, Acidic (Type I or LMW) (Epithelial Marker); Clone KRTL (Konsantre) | 0.1 ml |
RA0389-C.5 | Cytokeratin, Acidic (Type I or LMW) (Epithelial Marker); Clone KRTL (Konsantre) | 0.5 ml |
RA0383-C.1 | Cytokeratin, Basic (Type II or HMW) (Epithelial Marker); Clone 34BE12 (Konsantre) | 0.1 ml |
RA0383-C.5 | Cytokeratin, Basic (Type II or HMW) (Epithelial Marker); Clone 34BE12 (Konsantre) | 0.5 ml |
RA0386-C.1 | Cytokeratin, Basic (Type II or HMW) (Epithelial Marker); Clone AE-3 (Konsantre) | 0.1 ml |
RA0386-C.5 | Cytokeratin, Basic (Type II or HMW) (Epithelial Marker); Clone AE-3 (Konsantre) | 0.5 ml |
RA0390-C.1 | Cytokeratin, Basic (Type II or HMW) (Epithelial Marker); Clone KRTH (Konsantre) | 0.1 ml |
RA0390-C.5 | Cytokeratin, Basic (Type II or HMW) (Epithelial Marker); Clone KRTH (Konsantre) | 0.5 ml |
RA0381-C.1 | Cytokeratin, Multi (Epithelial Marker); Clone C11 (Konsantre) | 0.1 ml |
RA0381-C.5 | Cytokeratin, Multi (Epithelial Marker); Clone C11 (Konsantre) | 0.5 ml |
RA0382-C.1 | Cytokeratin, Pan (Epithelial Marker); Clone AE-1 & AE-3 (Konsantre) | 0.1 ml |
RA0382-C.5 | Cytokeratin, Pan (Epithelial Marker); Clone AE-1 & AE-3 (Konsantre) | 0.5 ml |
RA0391-C.1 | Cytokeratin, Pan (Epithelial Marker); Clone KRTL & KRTH (Konsantre) | 0.1 ml |
RA0391-C.5 | Cytokeratin, Pan (Epithelial Marker); Clone KRTL & KRTH (Konsantre) | 0.5 ml |
RA0391-C1 | Cytokeratin, Pan (Epithelial Marker); Clone KRTL & KRTH (Konsantre) | 1 ml |
RA0430-C.5 | Cytokeratin, pan (Epithelial Marker); Clone PAN-CK (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0459-C.1 | Desmin (Muscle Cell Marker); Clone D33 (Konsantre) | 0.1 ml |
RA0459-C.5 | Desmin (Muscle Cell Marker); Clone D33 (Konsantre) | 0.5 ml |
RA0459-C1 | Desmin (Muscle Cell Marker); Clone D33 (Konsantre) | 1 ml |
RA0362-C.1 | DOG-1 / TMEM16A (Marker for Gastrointestinal Stromal Tumors); Clone DG1/447 (Konsantre) | 0.1 ml |
RA0362-C.5 | DOG-1 / TMEM16A (Marker for Gastrointestinal Stromal Tumors); Clone DG1/447 (Konsantre) | 0.5 ml |
RA0364-C.1 | DOG-1 / TMEM16A (Marker for Gastrointestinal Stromal Tumors); Clone DG1/447 & DOG-1.1 (Konsantre) | 0.1 ml |
RA0364-C.5 | DOG-1 / TMEM16A (Marker for Gastrointestinal Stromal Tumors); Clone DG1/447 & DOG-1.1 (Konsantre) | 0.5 ml |
RA0363-C.1 | DOG-1 / TMEM16A (Marker for Gastrointestinal Stromal Tumors); Clone DOG-1.1 (Konsantre) | 0.1 ml |
RA0363-C.5 | DOG-1 / TMEM16A (Marker for Gastrointestinal Stromal Tumors); Clone DOG-1.1 (Konsantre) | 0.5 ml |
RA0363-C1 | DOG-1 / TMEM16A (Marker for Gastrointestinal Stromal Tumors); Clone DOG-1.1 (Konsantre) | 1 ml |
RA0417-C.1 | Double Stranded DNA (dsDNA) (Nuclear Marker); Clone 121-3 (Konsantre) | 0.1 ml |
RA0417-C.5 | Double Stranded DNA (dsDNA) (Nuclear Marker); Clone 121-3 (Konsantre) | 0.5 ml |
RA0418-C.1 | Double Stranded DNA (dsDNA) (Nuclear Marker); Clone AE-2 (Konsantre) | 0.1 ml |
RA0418-C.5 | Double Stranded DNA (dsDNA) (Nuclear Marker); Clone AE-2 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0107-C.1 | EGFR (Epidermal Growth Factor Receptor); Clone GFR450 (Konsantre) | 0.1 ml |
RA0107-C.5 | EGFR (Epidermal Growth Factor Receptor); Clone GFR450 (Konsantre) | 0.5 ml |
RA0199-C.1 | Ep-CAM / CD326 (Epithelial Marker); Clone EGP40/826 (Konsantre) | 0.1 ml |
RA0199-C.5 | Ep-CAM / CD326 (Epithelial Marker); Clone EGP40/826 (Konsantre) | 0.5 ml |
RA0200-C.1 | Ep-CAM / CD326 (Epithelial Marker); Clone EGP40/837 (Konsantre) | 0.1 ml |
RA0200-C.5 | Ep-CAM / CD326 (Epithelial Marker); Clone EGP40/837 (Konsantre) | 0.5 ml |
RA0198-C.1 | Ep-CAM / CD326 (Epithelial Marker); Clone HEA125 (Konsantre) | 0.1 ml |
RA0198-C.5 | Ep-CAM / CD326 (Epithelial Marker); Clone HEA125 (Konsantre) | 0.5 ml |
RA0196-C.1 | Ep-CAM / CD326 (Epithelial Marker); Clone MOC-31 (Konsantre) | 0.1 ml |
RA0196-C.5 | Ep-CAM / CD326 (Epithelial Marker); Clone MOC-31 (Konsantre) | 0.5 ml |
RA0195-C.1 | Ep-CAM / CD326 (Epithelial Marker); Clone VU-1D9 (Konsantre) | 0.1 ml |
RA0195-C.5 | Ep-CAM / CD326 (Epithelial Marker); Clone VU-1D9 (Konsantre) | 0.5 ml |
RA0111-C.1 | ER beta-1 (Estrogen Receptor beta-1); Clone ERb455 (Konsantre) | 0.1 ml |
RA0111-C.5 | ER beta-1 (Estrogen Receptor beta-1); Clone ERb455 (Konsantre) | 0.5 ml |
RA0436-C.1 | Erythropoietin (EPO); Clone EPO/1367 (Konsantre) | 0.1 ml |
RA0436-C.5 | Erythropoietin (EPO); Clone EPO/1367 (Konsantre) | 0.5 ml |
RA0436-C1 | Erythropoietin (EPO); Clone EPO/1367 (Konsantre) | 1 ml |
RA0445-C.1 | Erythropoietin (EPO); Clone EPO/1368 (Konsantre) | 0.1 ml |
RA0445-C.5 | Erythropoietin (EPO); Clone EPO/1368 (Konsantre) | 0.5 ml |
RA0445-C1 | Erythropoietin (EPO); Clone EPO/1368 (Konsantre) | 1 ml |
RA0110-C.1 | Estrogen Receptor (Marker of Estrogen Dependence); Clone ER505 (Konsantre) | 0.1 ml |
RA0110-C.5 | Estrogen Receptor (Marker of Estrogen Dependence); Clone ER505 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0450-C.1 | Fascin-1 (Reed-Sternberg Cell Marker); Clone FSCN1/417 (Konsantre) | 0.1 ml |
RA0450-C.5 | Fascin-1 (Reed-Sternberg Cell Marker); Clone FSCN1/417 (Konsantre) | 0.5 ml |
RA0450-C1 | Fascin-1 (Reed-Sternberg Cell Marker); Clone FSCN1/417 (Konsantre) | 1 ml |
RA0296-C.1 | Fascin-1; Clone FSCN1/417 (Konsantre) | 0.1 ml |
RA0296-C.5 | Fascin-1; Clone FSCN1/417 (Konsantre) | 0.5 ml |
RA0435-C.1 | FSH-beta (Follicle Stimulating Hormone-beta); Clone FSHb/1062 (Konsantre) | 0.1 ml |
RA0435-C.5 | FSH-beta (Follicle Stimulating Hormone-beta); Clone FSHb/1062 (Konsantre) | 0.5 ml |
RA0435-C1 | FSH-beta (Follicle Stimulating Hormone-beta); Clone FSHb/1062 (Konsantre) | 1 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0122-C.1 | GFAP (Astrocyte & Neural Stem Cell Marker); Clone ASTRO/789 (Konsantre) | 0.1 ml |
RA0122-C.5 | GFAP (Astrocyte & Neural Stem Cell Marker); Clone ASTRO/789 (Konsantre) | 0.5 ml |
RA0121-C.1 | GFAP (Astrocyte & Neural Stem Cell Marker); Clone GA-5 (Konsantre) | 0.1 ml |
RA0121-C.5 | GFAP (Astrocyte & Neural Stem Cell Marker); Clone GA-5 (Konsantre) | 0.5 ml |
RA0123-C.1 | GFAP (Astrocyte & Neural Stem Cell Marker); Clone GA-5 & ASTRO/789 (Konsantre) | 0.1 ml |
RA0123-C.5 | GFAP (Astrocyte & Neural Stem Cell Marker); Clone GA-5 & ASTRO/789 (Konsantre) | 0.5 ml |
RA0438-C.1 | Glycophorin A / CD235a (Erythrocyte Marker); Clone GYPA/280 (Konsantre) | 0.1 ml |
RA0438-C.5 | Glycophorin A / CD235a (Erythrocyte Marker); Clone GYPA/280 (Konsantre) | 0.5 ml |
RA0438-C1 | Glycophorin A / CD235a (Erythrocyte Marker); Clone GYPA/280 (Konsantre) | 1 ml |
RA0124-C.1 | Glypican-3 (GPC3) (Marker of Hepatocellular Carcinoma); Clone 1G12 (Konsantre) | 0.1 ml |
RA0124-C.5 | Glypican-3 (GPC3) (Marker of Hepatocellular Carcinoma); Clone 1G12 (Konsantre) | 0.5 ml |
RA0126-C.1 | Glypican-3 (GPC3) (Marker of Hepatocellular Carcinoma); Clone 1G12 & GPC3/863 (Konsantre) | 0.1 ml |
RA0126-C.5 | Glypican-3 (GPC3) (Marker of Hepatocellular Carcinoma); Clone 1G12 & GPC3/863 (Konsantre) | 0.5 ml |
RA0125-C.1 | Glypican-3 (GPC3) (Marker of Hepatocellular Carcinoma); Clone GPC3/863 (Konsantre) | 0.1 ml |
RA0125-C.5 | Glypican-3 (GPC3) (Marker of Hepatocellular Carcinoma); Clone GPC3/863 (Konsantre) | 0.5 ml |
RA0127-C.1 | GnRH-Receptor / LH-RH Receptor; Clone A9E4 (Konsantre) | 0.1 ml |
RA0127-C.5 | GnRH-Receptor / LH-RH Receptor; Clone A9E4 (Konsantre) | 0.5 ml |
RA0437-C.1 | GnRH-Receptor / LH-RH Receptor; Clone F1G4 (Konsantre) | 0.1 ml |
RA0437-C.5 | GnRH-Receptor / LH-RH Receptor; Clone F1G4 (Konsantre) | 0.5 ml |
RA0437-C1 | GnRH-Receptor / LH-RH Receptor; Clone F1G4 (Konsantre) | 1 ml |
RA0128-C.1 | GnRH-Receptor / LH-RH Receptor; Clone HH7/768 (Konsantre) | 0.1 ml |
RA0128-C.5 | GnRH-Receptor / LH-RH Receptor; Clone HH7/768 (Konsantre) | 0.5 ml |
RA0292-C.1 | gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker); Clone HMB45 (Konsantre) | 0.1 ml |
RA0292-C.5 | gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker); Clone HMB45 (Konsantre) | 0.5 ml |
RA0294-C.1 | gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker); Clone HMB45 & PMEL/783 (Konsantre) | 0.1 ml |
RA0294-C.5 | gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker); Clone HMB45 & PMEL/783 (Konsantre) | 0.5 ml |
RA0293-C.1 | gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker); Clone PMEL/783 (Konsantre) | 0.1 ml |
RA0293-C.5 | gp100 / Melanosome / PMEL17 / SILV (Melanoma Marker); Clone PMEL/783 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0399-C.1 | hCG Holo (Pregnancy & Choriocarcinoma Marker); Clone HCGab/52 (Konsantre) | 0.1 ml |
RA0399-C.5 | hCG Holo (Pregnancy & Choriocarcinoma Marker); Clone HCGab/52 (Konsantre) | 0.5 ml |
RA0504-C.1 | HCG-alpha (Pregnancy & Choriocarcinoma Marker); Clone SPM552 (Konsantre) | 0.1 ml |
RA0504-C.5 | HCG-alpha (Pregnancy & Choriocarcinoma Marker); Clone SPM552 (Konsantre) | 0.5 ml |
RA0504-C1 | HCG-alpha (Pregnancy & Choriocarcinoma Marker); Clone SPM552 (Konsantre) | 1 ml |
RA0086-C.1 | hCG-alpha; Clone HCGa/53 (Konsantre) | 0.1 ml |
RA0086-C.5 | hCG-alpha; Clone HCGa/53 (Konsantre) | 0.5 ml |
RA0508-C.1 | HCG-beta (Pregnancy & Choriocarcinoma Marker); Clone HCGb/211 (Konsantre) | 0.1 ml |
RA0508-C.5 | HCG-beta (Pregnancy & Choriocarcinoma Marker); Clone HCGb/211 (Konsantre) | 0.5 ml |
RA0508-C1 | HCG-beta (Pregnancy & Choriocarcinoma Marker); Clone HCGb/211 (Konsantre) | 1 ml |
RA0088-C.1 | hCG-beta (Pregnancy & Choriocarcinoma Marker); Clone HCGb/459 (Konsantre) | 0.1 ml |
RA0088-C.5 | hCG-beta (Pregnancy & Choriocarcinoma Marker); Clone HCGb/459 (Konsantre) | 0.5 ml |
RA0087-C.1 | hCG-beta (Pregnancy & Choriocarcinoma Marker); Clone HCGb/54 (Konsantre) | 0.1 ml |
RA0087-C.5 | hCG-beta (Pregnancy & Choriocarcinoma Marker); Clone HCGb/54 (Konsantre) | 0.5 ml |
RA0089-C.1 | hCG-beta (Pregnancy & Choriocarcinoma Marker); Clone HCGb/54 & HCGb/459 (Konsantre) | 0.1 ml |
RA0089-C.5 | hCG-beta (Pregnancy & Choriocarcinoma Marker); Clone HCGb/54 & HCGb/459 (Konsantre) | 0.5 ml |
RA0506-C.1 | HCG-beta (Pregnancy & Choriocarcinoma Marker); Clone SPM105 (Konsantre) | 0.1 ml |
RA0506-C.5 | HCG-beta (Pregnancy & Choriocarcinoma Marker); Clone SPM105 (Konsantre) | 0.5 ml |
RA0506-C1 | HCG-beta (Pregnancy & Choriocarcinoma Marker); Clone SPM105 (Konsantre) | 1 ml |
RA0507-C.1 | HCG-beta (Pregnancy & Choriocarcinoma Marker); Clone SPM529 (Konsantre) | 0.1 ml |
RA0507-C.5 | HCG-beta (Pregnancy & Choriocarcinoma Marker); Clone SPM529 (Konsantre) | 0.5 ml |
RA0507-C1 | HCG-beta (Pregnancy & Choriocarcinoma Marker); Clone SPM529 (Konsantre) | 1 ml |
RA0379-C.1 | Helicobacter Pylori; Rabbit Polyclonal (Konsantre) | 0.1 ml |
RA0379-C.5 | Helicobacter Pylori; Rabbit Polyclonal (Konsantre) | 0.5 ml |
RA0409-C.1 | Hepatocyte Specific Antigen (Hep Par 1) (Hepatocellular Marker); Clone OCH1E5 (Hep Par 1) (Konsantre) | 0.1 ml |
RA0409-C.5 | Hepatocyte Specific Antigen (Hep Par 1) (Hepatocellular Marker); Clone OCH1E5 (Hep Par 1) (Konsantre) | 0.5 ml |
RA0410-C.1 | Hepatocyte Specific Antigen (Hepatocellular Marker); Clone HSA98 (Konsantre) | 0.1 ml |
RA0410-C.5 | Hepatocyte Specific Antigen (Hepatocellular Marker); Clone HSA98 (Konsantre) | 0.5 ml |
RA0108-C.1 | HER-2 / c-erbB-2 / neu / CD340; Clone HRB2/451 (Konsantre) | 0.1 ml |
RA0108-C.5 | HER-2 / c-erbB-2 / neu / CD340; Clone HRB2/451 (Konsantre) | 0.5 ml |
RA0380-C.1 | HPV-16 (Human Papilloma Virus 16); Clone CAMVIR-1 (Konsantre) | 0.1 ml |
RA0380-C.5 | HPV-16 (Human Papilloma Virus 16); Clone CAMVIR-1 (Konsantre) | 0.5 ml |
RA0380-C1 | HPV-16 (Human Papilloma Virus 16); Clone CAMVIR-1 (Konsantre) | 1 ml |
RA0132-C.1 | HSP27 (Heat Shock Protein 27); Clone 24K/774 (Konsantre) | 0.1 ml |
RA0132-C.5 | HSP27 (Heat Shock Protein 27); Clone 24K/774 (Konsantre) | 0.5 ml |
RA0131-C.1 | HSP27 (Heat Shock Protein 27); Clone G3.1 (Konsantre) | 0.1 ml |
RA0131-C.5 | HSP27 (Heat Shock Protein 27); Clone G3.1 (Konsantre) | 0.5 ml |
RA0134-C.1 | HSP60 (Heat Shock Protein 60); Clone HLD4/780 (Konsantre) | 0.1 ml |
RA0134-C.5 | HSP60 (Heat Shock Protein 60); Clone HLD4/780 (Konsantre) | 0.5 ml |
RA0133-C.1 | HSP60 (Heat Shock Protein 60); Clone LK1 (Konsantre) | 0.1 ml |
RA0133-C.5 | HSP60 (Heat Shock Protein 60); Clone LK1 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0137-C.1 | IgA (Immunoglobulin Alpha Heavy Chain) (B-Cell Marker); Clone GA01 (Konsantre) | 0.1 ml |
RA0137-C.5 | IgA (Immunoglobulin Alpha Heavy Chain) (B-Cell Marker); Clone GA01 (Konsantre) | 0.5 ml |
RA0136-C.1 | IgA (Immunoglobulin Alpha Heavy Chain) (B-Cell Marker); Clone HISA3 (Konsantre) | 0.1 ml |
RA0136-C.5 | IgA (Immunoglobulin Alpha Heavy Chain) (B-Cell Marker); Clone HISA3 (Konsantre) | 0.5 ml |
RA0138-C.1 | IgA (Immunoglobulin Alpha Heavy Chain) (B-Cell Marker); Clone HISA3 & GA01 (Konsantre) | 0.1 ml |
RA0138-C.5 | IgA (Immunoglobulin Alpha Heavy Chain) (B-Cell Marker); Clone HISA3 & GA01 (Konsantre) | 0.5 ml |
RA0142-C.1 | IgG (Immunoglobulin Gamma Heavy Chain) (B-Cell Marker); Clone B33/20 (Konsantre) | 0.1 ml |
RA0142-C.5 | IgG (Immunoglobulin Gamma Heavy Chain) (B-Cell Marker); Clone B33/20 (Konsantre) | 0.5 ml |
RA0139-C.1 | IgG (Immunoglobulin Gamma Heavy Chain) (B-Cell Marker); Clone IG217 (Konsantre) | 0.1 ml |
RA0139-C.5 | IgG (Immunoglobulin Gamma Heavy Chain) (B-Cell Marker); Clone IG217 (Konsantre) | 0.5 ml |
RA0141-C.1 | IgG (Immunoglobulin Gamma Heavy Chain) (B-Cell Marker); Clone IG217 & IG266 (Konsantre) | 0.1 ml |
RA0141-C.5 | IgG (Immunoglobulin Gamma Heavy Chain) (B-Cell Marker); Clone IG217 & IG266 (Konsantre) | 0.5 ml |
RA0140-C.1 | IgG (Immunoglobulin Gamma Heavy Chain) (B-Cell Marker); Clone IG266 (Konsantre) | 0.1 ml |
RA0140-C.5 | IgG (Immunoglobulin Gamma Heavy Chain) (B-Cell Marker); Clone IG266 (Konsantre) | 0.5 ml |
RA0144-C.1 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone DA4-4 (SA-DA4 or HB57) (Konsantre) | 0.1 ml |
RA0144-C.5 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone DA4-4 (SA-DA4 or HB57) (Konsantre) | 0.5 ml |
RA0143-C.1 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone ICO-30 (Konsantre) | 0.1 ml |
RA0143-C.5 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone ICO-30 (Konsantre) | 0.5 ml |
RA0145-C.1 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone IM260 (Konsantre) | 0.1 ml |
RA0145-C.5 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone IM260 (Konsantre) | 0.5 ml |
RA0147-C.1 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone IM260 & ICO-30 (Konsantre) | 0.1 ml |
RA0147-C.5 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone IM260 & ICO-30 (Konsantre) | 0.5 ml |
RA0146-C.1 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone IM373 (Konsantre) | 0.1 ml |
RA0146-C.5 | IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker); Clone IM373 (Konsantre) | 0.5 ml |
RA0161-C.1 | Insulin / IRDN (Beta Cell & Insulinoma Marker); Clone 2D11-H5 (INS05) (Konsantre) | 0.1 ml |
RA0161-C.5 | Insulin / IRDN (Beta Cell & Insulinoma Marker); Clone 2D11-H5 (INS05) (Konsantre) | 0.5 ml |
RA0163-C.1 | Insulin / IRDN (Beta Cell & Insulinoma Marker); Clone E2-E3 & 2D11-H5 (INS04 & INS05) (Konsantre) | 0.1 ml |
RA0163-C.5 | Insulin / IRDN (Beta Cell & Insulinoma Marker); Clone E2-E3 & 2D11-H5 (INS04 & INS05) (Konsantre) | 0.5 ml |
RA0162-C.1 | Insulin / IRDN (Beta Cell & Insulinoma Marker); Clone E2-E3 (INS04) (Konsantre) | 0.1 ml |
RA0162-C.5 | Insulin / IRDN (Beta Cell & Insulinoma Marker); Clone E2-E3 (INS04) (Konsantre) | 0.5 ml |
RA0164-C.1 | Insulin / IRDN (Beta Cell & Insulinoma Marker); Clone IRDN/794 (Konsantre) | 0.1 ml |
RA0164-C.5 | Insulin / IRDN (Beta Cell & Insulinoma Marker); Clone IRDN/794 (Konsantre) | 0.5 ml |
RA0165-C.1 | Insulin / IRDN (Beta Cell & Insulinoma Marker); Clone IRDN/805 (Konsantre) | 0.1 ml |
RA0165-C.5 | Insulin / IRDN (Beta Cell & Insulinoma Marker); Clone IRDN/805 (Konsantre) | 0.5 ml |
RA0167-C.1 | Involucrin (Squamous Cell Terminal Differentiation Marker); Clone IVRN/827 (Konsantre) | 0.1 ml |
RA0167-C.5 | Involucrin (Squamous Cell Terminal Differentiation Marker); Clone IVRN/827 (Konsantre) | 0.5 ml |
RA0166-C.1 | Involucrin (Squamous Cell Terminal Differentiation Marker); Clone SY5 (Konsantre) | 0.1 ml |
RA0166-C.5 | Involucrin (Squamous Cell Terminal Differentiation Marker); Clone SY5 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0151-C.1 | Kappa Light Chain (B-Cell marker); Clone HP6053 (Konsantre) | 0.1 ml |
RA0151-C.5 | Kappa Light Chain (B-Cell marker); Clone HP6053 (Konsantre) | 0.5 ml |
RA0152-C.1 | Kappa Light Chain (B-Cell marker); Clone HP6053 & L1C1 (Konsantre) | 0.1 ml |
RA0152-C.5 | Kappa Light Chain (B-Cell marker); Clone HP6053 & L1C1 (Konsantre) | 0.5 ml |
RA0154-C.1 | Kappa Light Chain (B-Cell marker); Clone Kap-56 (Konsantre) | 0.1 ml |
RA0154-C.5 | Kappa Light Chain (B-Cell marker); Clone Kap-56 (Konsantre) | 0.5 ml |
RA0149-C.1 | Kappa Light Chain (B-Cell marker); Clone KLC264 (Konsantre) | 0.1 ml |
RA0149-C.5 | Kappa Light Chain (B-Cell marker); Clone KLC264 (Konsantre) | 0.5 ml |
RA0153-C.1 | Kappa Light Chain (B-Cell marker); Clone KLC709 (Konsantre) | 0.1 ml |
RA0153-C.5 | Kappa Light Chain (B-Cell marker); Clone KLC709 (Konsantre) | 0.5 ml |
RA0153-C1 | Kappa Light Chain (B-Cell marker); Clone KLC709 (Konsantre) | 1 ml |
RA0148-C.1 | Kappa Light Chain (B-Cell marker); Clone L1C1 (Konsantre) | 0.1 ml |
RA0148-C.5 | Kappa Light Chain (B-Cell marker); Clone L1C1 (Konsantre) | 0.5 ml |
RA0150-C.1 | Kappa Light Chain (B-Cell marker); Clone TB28-2 (Konsantre) | 0.1 ml |
RA0150-C.5 | Kappa Light Chain (B-Cell marker); Clone TB28-2 (Konsantre) | 0.5 ml |
RA0416-C.1 | KBA.62 (Melanoma Associated Antigen); Clone KBA.62 (Konsantre) | 0.1 ml |
RA0416-C.5 | KBA.62 (Melanoma Associated Antigen); Clone KBA.62 (Konsantre) | 0.5 ml |
RA0431-C.1 | Ksp-Cadherin (Kidney-Specific Cadherin) / CDH16; Clone CDH16/1071 (Konsantre) | 0.1 ml |
RA0431-C.5 | Ksp-Cadherin (Kidney-Specific Cadherin) / CDH16; Clone CDH16/1071 (Konsantre) | 0.5 ml |
RA0431-C1 | Ksp-Cadherin (Kidney-Specific Cadherin) / CDH16; Clone CDH16/1071 (Konsantre) | 1 ml |
RA0470-C.1 | Ksp-Cadherin (Kidney-Specific Cadherin) / CDH16; Clone CDH16/1532R (Konsantre) | 0.1 ml |
RA0470-C.5 | Ksp-Cadherin (Kidney-Specific Cadherin) / CDH16; Clone CDH16/1532R (Konsantre) | 0.5 ml |
RA0470-C1 | Ksp-Cadherin (Kidney-Specific Cadherin) / CDH16; Clone CDH16/1532R (Konsantre) | 1 ml |
RA0468-C.1 | Ksp-Cadherin (Kidney-Specific Cadherin) / CDH16; Clone rCDH16/1071 (Konsantre) | 0.1 ml |
RA0468-C.5 | Ksp-Cadherin (Kidney-Specific Cadherin) / CDH16; Clone rCDH16/1071 (Konsantre) | 0.5 ml |
RA0468-C1 | Ksp-Cadherin (Kidney-Specific Cadherin) / CDH16; Clone rCDH16/1071 (Konsantre) | 1 ml |
RA0469-C.1 | Ksp-Cadherin (Kidney-Specific Cadherin) / CDH16; Clone SPM594 (Konsantre) | 0.1 ml |
RA0469-C.5 | Ksp-Cadherin (Kidney-Specific Cadherin) / CDH16; Clone SPM594 (Konsantre) | 0.5 ml |
RA0469-C1 | Ksp-Cadherin (Kidney-Specific Cadherin) / CDH16; Clone SPM594 (Konsantre) | 1 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0156-C.1 | Lambda Light Chain (B-Cell Marker); Clone HP6054 (Konsantre) | 0.1 ml |
RA0156-C.5 | Lambda Light Chain (B-Cell Marker); Clone HP6054 (Konsantre) | 0.5 ml |
RA0155-C.1 | Lambda Light Chain (B-Cell Marker); Clone ICO-106 (Konsantre) | 0.1 ml |
RA0155-C.5 | Lambda Light Chain (B-Cell Marker); Clone ICO-106 (Konsantre) | 0.5 ml |
RA0158-C.1 | Lambda Light Chain (B-Cell Marker); Clone LAM03 (Konsantre) | 0.1 ml |
RA0158-C.5 | Lambda Light Chain (B-Cell Marker); Clone LAM03 (Konsantre) | 0.5 ml |
RA0160-C.1 | Lambda Light Chain (B-Cell Marker); Clone Lamb14 (Konsantre) | 0.1 ml |
RA0160-C.5 | Lambda Light Chain (B-Cell Marker); Clone Lamb14 (Konsantre) | 0.5 ml |
RA0157-C.1 | Lambda Light Chain (B-Cell Marker); Clone LcN-2 (Konsantre) | 0.1 ml |
RA0157-C.5 | Lambda Light Chain (B-Cell Marker); Clone LcN-2 (Konsantre) | 0.5 ml |
RA0159-C.1 | Lambda Light Chain (B-Cell Marker); Clone LcN-2 & ICO-106 (Konsantre) | 0.1 ml |
RA0159-C.5 | Lambda Light Chain (B-Cell Marker); Clone LcN-2 & ICO-106 (Konsantre) | 0.5 ml |
RA0505-C.1 | LH, alpha (Luteinizing Hormone, alpha); Clone LHa/756 (Konsantre) | 0.1 ml |
RA0505-C.5 | LH, alpha (Luteinizing Hormone, alpha); Clone LHa/756 (Konsantre) | 0.5 ml |
RA0505-C1 | LH, alpha (Luteinizing Hormone, alpha); Clone LHa/756 (Konsantre) | 1 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0288-C.1 | Macrophage Marker (Calgranulin A/B); Clone CAG/426 (Konsantre) | 0.1 ml |
RA0288-C.5 | Macrophage Marker (Calgranulin A/B); Clone CAG/426 (Konsantre) | 0.5 ml |
RA0287-C.1 | Macrophage Marker (Macrophage L1 Protein) (Calprotectin); Clone MAC387 (Konsantre) | 0.1 ml |
RA0287-C.5 | Macrophage Marker (Macrophage L1 Protein) (Calprotectin); Clone MAC387 (Konsantre) | 0.5 ml |
RA0290-C.1 | Macrophage Marker (Myeloid-Related Proteins 8/14) (MRP-8/MRP-14); Clone MRP/840 (Konsantre) | 0.1 ml |
RA0290-C.5 | Macrophage Marker (Myeloid-Related Proteins 8/14) (MRP-8/MRP-14); Clone MRP/840 (Konsantre) | 0.5 ml |
RA0289-C.1 | Macrophage Marker (S100A8/A9); Clone S100/722 (Konsantre) | 0.1 ml |
RA0289-C.5 | Macrophage Marker (S100A8/A9); Clone S100/722 (Konsantre) | 0.5 ml |
RA0201-C.1 | MAGE-1 (Target for Cancer Immunotherapy); Clone MA454 (Konsantre) | 0.1 ml |
RA0201-C.5 | MAGE-1 (Target for Cancer Immunotherapy); Clone MA454 (Konsantre) | 0.5 ml |
RA0202-C.1 | MAGE-1 (Target for Cancer Immunotherapy); Clone MZ2E/838 (Konsantre) | 0.1 ml |
RA0202-C.5 | MAGE-1 (Target for Cancer Immunotherapy); Clone MZ2E/838 (Konsantre) | 0.5 ml |
RA0349-C.1 | Major Vault Protein (MVP); Clone 1014 (Konsantre) | 0.1 ml |
RA0349-C.5 | Major Vault Protein (MVP); Clone 1014 (Konsantre) | 0.5 ml |
RA0350-C.1 | Major Vault Protein (MVP); Clone 1032 (Konsantre) | 0.1 ml |
RA0350-C.5 | Major Vault Protein (MVP); Clone 1032 (Konsantre) | 0.5 ml |
RA0352-C.1 | MALT1 (MALT-Lymphoma Marker); Clone MT1/410 (Konsantre) | 0.1 ml |
RA0352-C.5 | MALT1 (MALT-Lymphoma Marker); Clone MT1/410 (Konsantre) | 0.5 ml |
RA0509-C.1 | MALT1 (MALT-Lymphoma Marker); Clone SPM578 (Konsantre) | 0.1 ml |
RA0509-C.5 | MALT1 (MALT-Lymphoma Marker); Clone SPM578 (Konsantre) | 0.5 ml |
RA0509-C1 | MALT1 (MALT-Lymphoma Marker); Clone SPM578 (Konsantre) | 1 ml |
RA0114-C.1 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone A103 (Konsantre) | 0.1 ml |
RA0114-C.5 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone A103 (Konsantre) | 0.5 ml |
RA0114-C1 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone A103 (Konsantre) | 1 ml |
RA0115-C.1 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone A103, M2-7C10 & M2-9E3 (Konsantre) | 0.1 ml |
RA0115-C.5 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone A103, M2-7C10 & M2-9E3 (Konsantre) | 0.5 ml |
RA0117-C.1 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone DT101 & BC199 (Konsantre) | 0.1 ml |
RA0117-C.5 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone DT101 & BC199 (Konsantre) | 0.5 ml |
RA0112-C.1 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone M2-7C10 (Konsantre) | 0.1 ml |
RA0112-C.5 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone M2-7C10 (Konsantre) | 0.5 ml |
RA0116-C.1 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone M2-7C10 & M2-9E3 (Konsantre) | 0.1 ml |
RA0116-C.5 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone M2-7C10 & M2-9E3 (Konsantre) | 0.5 ml |
RA0113-C.1 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone M2-9E3 (Konsantre) | 0.1 ml |
RA0113-C.5 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone M2-9E3 (Konsantre) | 0.5 ml |
RA0118-C.1 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone MLANA/788 (Konsantre) | 0.1 ml |
RA0118-C.5 | MART-1 / Melan-A / MLANA (Melanoma Marker); Clone MLANA/788 (Konsantre) | 0.5 ml |
RA0442-C.1 | MCAM (Melanoma Cell Adhesion Molecule) / MUC18 / CD146; Clone MCAM/1101 (Konsantre) | 0.1 ml |
RA0442-C.5 | MCAM (Melanoma Cell Adhesion Molecule) / MUC18 / CD146; Clone MCAM/1101 (Konsantre) | 0.5 ml |
RA0442-C1 | MCAM (Melanoma Cell Adhesion Molecule) / MUC18 / CD146; Clone MCAM/1101 (Konsantre) | 1 ml |
RA0444-C.1 | MCAM (Melanoma Cell Adhesion Molecule) / MUC18 / CD146; Clone MUC18/1130 (Konsantre) | 0.1 ml |
RA0444-C.5 | MCAM (Melanoma Cell Adhesion Molecule) / MUC18 / CD146; Clone MUC18/1130 (Konsantre) | 0.5 ml |
RA0444-C1 | MCAM (Melanoma Cell Adhesion Molecule) / MUC18 / CD146; Clone MUC18/1130 (Konsantre) | 1 ml |
RA0443-C.1 | MCAM (Melanoma Cell Adhesion) / MUC18 / CD146; Clone C146/634 (Konsantre) | 0.1 ml |
RA0443-C.5 | MCAM (Melanoma Cell Adhesion) / MUC18 / CD146; Clone C146/634 (Konsantre) | 0.5 ml |
RA0443-C1 | MCAM (Melanoma Cell Adhesion) / MUC18 / CD146; Clone C146/634 (Konsantre) | 1 ml |
RA0413-C.1 | Melanoma Marker (MART-1 & gp100); Clone DT101, BC199, & HMB45 (Konsantre) | 0.1 ml |
RA0413-C.5 | Melanoma Marker (MART-1 & gp100); Clone DT101, BC199, & HMB45 (Konsantre) | 0.5 ml |
RA0412-C.1 | Melanoma Marker (MART-1, Tyrosinase, & gp100); Clone A103, T311, & HMB45 (Konsantre) | 0.1 ml |
RA0412-C.5 | Melanoma Marker (MART-1, Tyrosinase, & gp100); Clone A103, T311, & HMB45 (Konsantre) | 0.5 ml |
RA0414-C.1 | Melanoma Marker (MART-1, Tyrosinase, & gp100); Clone DT101, BC199, T311, & HMB45 (Konsantre) | 0.1 ml |
ARAŞTIRMA ANTİKORLARI RUO | DİLÜSYON ORANLARI | |
---|---|---|
RA0414-C.5 | Melanoma Marker (MART-1, Tyrosinase, & gp100); Clone DT101, BC199, T311, & HMB45 (Konsantre) | 0.5 ml |
RA0411-C.1 | Melanoma Marker (MART-1, Tyrosinase, & gp100); Clone M2-7C10, M2-9E3, T311, & HMB45 (Konsantre) | 0.1 ml |
RA0411-C.5 | Melanoma Marker (MART-1, Tyrosinase, & gp100); Clone M2-7C10, M2-9E3, T311, & HMB45 (Konsantre) | 0.5 ml |
RA0411-C1 | Melanoma Marker (MART-1, Tyrosinase, & gp100); Clone M2-7C10, M2-9E3, T311, & HMB45 (Konsantre) | 1 ml |
RA0207-C.1 | Microphthalmia Transcription Factor (MITF); Clone D5 (Konsantre) | 0.1 ml |
RA0207-C.5 | Microphthalmia Transcription Factor (MITF); Clone D5 (Konsantre) | 0.5 ml |
RA0210-C.1 | Microphthalmia Transcription Factor (MITF); Clone D5 & MITF/915 (Konsantre) | 0.1 ml |
RA0210-C.5 | Microphthalmia Transcription Factor (MITF); Clone D5 & MITF/915 (Konsantre) | 0.5 ml |
RA0208-C.1 | Microphthalmia Transcription Factor (MITF); Clone MITF/915 (Konsantre) | 0.1 ml |
RA0208-C.5 | Microphthalmia Transcription Factor (MITF); Clone MITF/915 (Konsantre) | 0.5 ml |
RA0396-C.1 | Mitochondria (Marker for Human Cells); Clone AE-1 (Konsantre) | 0.1 ml |
RA0396-C.5 | Mitochondria (Marker for Human Cells); Clone AE-1 (Konsantre) | 0.5 ml |
RA0393-C.1 | Mitochondria (Marker for Human Cells); Clone MTC02 (Konsantre) | 0.1 ml |
RA0393-C.5 | Mitochondria (Marker for Human Cells); Clone MTC02 (Konsantre) | 0.5 ml |
RA0392-C.1 | Mitochondria (Marker for Human Cells, Granular RCC's & Salivary Tumors); Clone 113-1 (Konsantre) | 0.1 ml |
RA0392-C.5 | Mitochondria (Marker for Human Cells, Granular RCC's & Salivary Tumors); Clone 113-1 (Konsantre) | 0.5 ml |
RA0394-C.1 | Mitochondrial Marker; Clone MTC719 (Konsantre) | 0.1 ml |
RA0394-C.5 | Mitochondrial Marker; Clone MTC719 (Konsantre) | 0.5 ml |
RA0395-C.1 | Mitochondrial Marker; Clone MTC754 (Konsantre) | 0.1 ml |
RA0395-C.5 | Mitochondrial Marker; Clone MTC754 (Konsantre) | 0.5 ml |
RA0211-C.1 | Moesin; Clone MSN491 (Konsantre) | 0.1 ml |
RA0211-C.5 | Moesin; Clone MSN491 (Konsantre) | 0.5 ml |
RA0217-C.1 | MUC1 / EMA / CD227 (Epithelial Marker); Clone 139H2 (Konsantre) | 0.1 ml |
RA0217-C.5 | MUC1 / EMA / CD227 (Epithelial Marker); Clone 139H2 (Konsantre) | 0.5 ml |
RA0214-C.1 | MUC1 / EMA / CD227 (Epithelial Marker); Clone E29 (Konsantre) | 0.1 ml |
RA0214-C.5 | MUC1 / EMA / CD227 (Epithelial Marker); Clone E29 (Konsantre) | 0.5 ml |
RA0212-C.1 | MUC1 / EMA / CD227 (Epithelial Marker); Clone GP1.4 (Konsantre) | 0.1 ml |
RA0212-C.5 | MUC1 / EMA / CD227 (Epithelial Marker); Clone GP1.4 (Konsantre) | 0.5 ml |
RA0215-C.1 | MUC1 / EMA / CD227 (Epithelial Marker); Clone GP1.4 & E29 (Konsantre) | 0.1 ml |
RA0215-C.5 | MUC1 / EMA / CD227 (Epithelial Marker); Clone GP1.4 & E29 (Konsantre) | 0.5 ml |
RA0218-C.1 | MUC1 / EMA / CD227 (Epithelial Marker); Clone HMPV (Konsantre) | 0.1 ml |
RA0218-C.5 | MUC1 / EMA / CD227 (Epithelial Marker); Clone HMPV (Konsantre) | 0.5 ml |
RA0216-C.1 | MUC1 / EMA / CD227 (Epithelial Marker); Clone PEM/845 (Konsantre) | 0.1 ml |
RA0216-C.5 | MUC1 / EMA / CD227 (Epithelial Marker); Clone PEM/845 (Konsantre) | 0.5 ml |
RA0219-C.1 | MUC2 (Mucin 2); Clone CCP58 (Konsantre) | 0.1 ml |
RA0219-C.5 | MUC2 (Mucin 2); Clone CCP58 (Konsantre) | 0.5 ml |
RA0220-C.1 | MUC2 (Mucin 2); Clone MLP/842 (Konsantre) | 0.1 ml |
RA0220-C.5 | MUC2 (Mucin 2); Clone MLP/842 (Konsantre) | 0.5 ml |
RA0221-C.1 | MUC5AC (Mucin 5AC / Gastric Mucin); Clone 45M1 (Konsantre) | 0.1 ml |
RA0221-C.5 | MUC5AC (Mucin 5AC / Gastric Mucin); Clone 45M1 (Konsantre) | 0.5 ml |
RA0222-C.1 | MUC5AC (Mucin 5AC / Gastric Mucin); Clone CLH2 (Konsantre) | 0.1 ml |
RA0222-C.5 | MUC5AC (Mucin 5AC / Gastric Mucin); Clone CLH2 (Konsantre) | 0.5 ml |
RA0223-C.1 | MUC5AC (Mucin 5AC / Gastric Mucin); Clone MUC5AC/917 (Konsantre) | 0.1 ml |
RA0223-C.5 | MUC5AC (Mucin 5AC / Gastric Mucin); Clone MUC5AC/917 (Konsantre) | 0.5 ml |
RA0224-C.1 | MUC6 (Mucin 6 / Gastric Mucin); Clone CLH5 (Konsantre) | 0.1 ml |
RA0224-C.5 | MUC6 (Mucin 6 / Gastric Mucin); Clone CLH5 (Konsantre) | 0.5 ml |
RA0225-C.1 | MUC6 (Mucin 6 / Gastric Mucin); Clone MUC6/916 (Konsantre) | 0.1 ml |
RA0225-C.5 | MUC6 (Mucin 6 / Gastric Mucin); Clone MUC6/916 (Konsantre) | 0.5 ml |
RA0400-C.1 | Myeloid Cell Marker (Macrophage / Granulocyte Marker); Clone BM-1 (Konsantre) | 0.1 ml |
RA0400-C.5 | Myeloid Cell Marker (Macrophage / Granulocyte Marker); Clone BM-1 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | DİLÜSYON ORANLARI | |
---|---|---|
RA0366-C.1 | Myeloid-Associated Differentiation Marker (MYADM); Clone BM-2 (Konsantre) | 0.1 ml |
RA0366-C.5 | Myeloid-Associated Differentiation Marker (MYADM); Clone BM-2 (Konsantre) | 0.5 ml |
RA0455-C.1 | Myeloid-Associated Differentiation Marker (MYADM); Clone MYADM/971 (Konsantre) | 0.1 ml |
RA0455-C.5 | Myeloid-Associated Differentiation Marker (MYADM); Clone MYADM/971 (Konsantre) | 0.5 ml |
RA0455-C1 | Myeloid-Associated Differentiation Marker (MYADM); Clone MYADM/971 (Konsantre) | 1 ml |
RA0456-C.1 | Myeloid-Associated Differentiation Marker (MYADM); Clone MYADM/972 (Konsantre) | 0.1 ml |
RA0456-C.5 | Myeloid-Associated Differentiation Marker (MYADM); Clone MYADM/972 (Konsantre) | 0.5 ml |
RA0456-C1 | Myeloid-Associated Differentiation Marker (MYADM); Clone MYADM/972 (Konsantre) | 1 ml |
RA0231-C.1 | MyoD1 (Rhabdomyosarcoma Marker); Clone 5.8A (Konsantre) | 0.1 ml |
RA0231-C.5 | MyoD1 (Rhabdomyosarcoma Marker); Clone 5.8A (Konsantre) | 0.5 ml |
RA0233-C.1 | MyoD1 (Rhabdomyosarcoma Marker); Clone 5.8A & MYD712 (Konsantre) | 0.1 ml |
RA0233-C.5 | MyoD1 (Rhabdomyosarcoma Marker); Clone 5.8A & MYD712 (Konsantre) | 0.5 ml |
RA0232-C.1 | MyoD1 (Rhabdomyosarcoma Marker); Clone MYD712 (Konsantre) | 0.1 ml |
RA0232-C.5 | MyoD1 (Rhabdomyosarcoma Marker); Clone MYD712 (Konsantre) | 0.5 ml |
RA0235-C.1 | Myogenin (Skeletal Muscle Marker); Clone F5D (Konsantre) | 0.1 ml |
RA0235-C.5 | Myogenin (Skeletal Muscle Marker); Clone F5D (Konsantre) | 0.5 ml |
RA0235-C1 | Myogenin (Skeletal Muscle Marker); Clone F5D (Konsantre) | 1 ml |
RA0234-C.1 | Myogenin (Skeletal Muscle Marker); Clone MGN185 (Konsantre) | 0.1 ml |
RA0234-C.5 | Myogenin (Skeletal Muscle Marker); Clone MGN185 (Konsantre) | 0.5 ml |
RA0236-C.1 | Myogenin (Skeletal Muscle Marker); Clone MGN185 & F5D (Konsantre) | 0.1 ml |
RA0236-C.5 | Myogenin (Skeletal Muscle Marker); Clone MGN185 & F5D (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0479-C.1 | Napsin A (Lung Adenocarcinoma Marker); Clones NAPSA/1238 & NAPSA/1239 (Konsantre) | 0.1 ml |
RA0479-C.5 | Napsin A (Lung Adenocarcinoma Marker); Clones NAPSA/1238 & NAPSA/1239 (Konsantre) | 0.5 ml |
RA0479-C1 | Napsin A (Lung Adenocarcinoma Marker); Clones NAPSA/1238 & NAPSA/1239 (Konsantre) | 1 ml |
RA0348-C.1 | Napsin A (Lung Adenocarcinoma Marker); Rabbit Polyclonal (Konsantre) | 0.1 ml |
RA0348-C.5 | Napsin A (Lung Adenocarcinoma Marker); Rabbit Polyclonal (Konsantre) | 0.5 ml |
RA0463-C.1 | N-Cadherin / Cadherin-2 / CD325 (NCAD); Clone 13A9 (Konsantre) | 0.1 ml |
RA0463-C.5 | N-Cadherin / Cadherin-2 / CD325 (NCAD); Clone 13A9 (Konsantre) | 0.5 ml |
RA0463-C1 | N-Cadherin / Cadherin-2 / CD325 (NCAD); Clone 13A9 (Konsantre) | 1 ml |
RA0464-C.1 | N-Cadherin / Cadherin-2 / CD325 (NCAD); Clone 8C11 (Konsantre) | 0.1 ml |
RA0464-C.5 | N-Cadherin / Cadherin-2 / CD325 (NCAD); Clone 8C11 (Konsantre) | 0.5 ml |
RA0464-C1 | N-Cadherin / Cadherin-2 / CD325 (NCAD); Clone 8C11 (Konsantre) | 1 ml |
RA0465-C.1 | N-Cadherin / Cadherin-2 / CD325 (NCAD); Clone CDH2/1573 (Konsantre) | 0.1 ml |
RA0465-C.5 | N-Cadherin / Cadherin-2 / CD325 (NCAD); Clone CDH2/1573 (Konsantre) | 0.5 ml |
RA0465-C1 | N-Cadherin / Cadherin-2 / CD325 (NCAD); Clone CDH2/1573 (Konsantre) | 1 ml |
RA0408-C.1 | Neurofilament (H & L) (Neuronal Marker); Clone NF421 & NFL/736 (Konsantre) | 0.1 ml |
RA0408-C.5 | Neurofilament (H & L) (Neuronal Marker); Clone NF421 & NFL/736 (Konsantre) | 0.5 ml |
RA0407-C.1 | Neurofilament (H & L) (Neuronal Marker); Clone RT97 & NR-4 (Konsantre) | 0.1 ml |
RA0407-C.5 | Neurofilament (H & L) (Neuronal Marker); Clone RT97 & NR-4 (Konsantre) | 0.5 ml |
RA0243-C.1 | Neurofilament (NF-H) (Neuronal Marker); Clone NF421 (Konsantre) | 0.1 ml |
RA0243-C.5 | Neurofilament (NF-H) (Neuronal Marker); Clone NF421 (Konsantre) | 0.5 ml |
RA0244-C.1 | Neurofilament (NF-H) (Neuronal Marker); Clone RT97 (Konsantre) | 0.1 ml |
RA0244-C.5 | Neurofilament (NF-H) (Neuronal Marker); Clone RT97 (Konsantre) | 0.5 ml |
RA0246-C.1 | Neurofilament (NF-L) (Neuronal Marker); Clone NFL/736 (Konsantre) | 0.1 ml |
RA0246-C.5 | Neurofilament (NF-L) (Neuronal Marker); Clone NFL/736 (Konsantre) | 0.5 ml |
RA0245-C.1 | Neurofilament (NF-L) (Neuronal Marker); Clone NR-4 (Konsantre) | 0.1 ml |
RA0245-C.5 | Neurofilament (NF-L) (Neuronal Marker); Clone NR-4 (Konsantre) | 0.5 ml |
RA0247-C.1 | NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker); Clone NGFR5 (Konsantre) | 0.1 ml |
RA0247-C.5 | NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker); Clone NGFR5 (Konsantre) | 0.5 ml |
RA0249-C.1 | NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker); Clone NGFR5 & NTR/912 (Konsantre) | 0.1 ml |
RA0249-C.5 | NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker); Clone NGFR5 & NTR/912 (Konsantre) | 0.5 ml |
RA0248-C.1 | NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker); Clone NTR/912 (Konsantre) | 0.1 ml |
RA0248-C.5 | NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker); Clone NTR/912 (Konsantre) | 0.5 ml |
RA0250-C.1 | NKX2.2 (Neuroendocrine & Ewing Sarcoma Marker); Clone NX2/294 (Konsantre) | 0.1 ml |
RA0250-C.5 | NKX2.2 (Neuroendocrine & Ewing Sarcoma Marker); Clone NX2/294 (Konsantre) | 0.5 ml |
RA0462-C.1 | NSE gamma (Neuron Specific Enolase, gamma) (Neuroendocrine Marker); Clone ENO2/1462 (Konsantre) | 0.1 ml |
RA0462-C.5 | NSE gamma (Neuron Specific Enolase, gamma) (Neuroendocrine Marker); Clone ENO2/1462 (Konsantre) | 0.5 ml |
RA0462-C1 | NSE gamma (Neuron Specific Enolase, gamma) (Neuroendocrine Marker); Clone ENO2/1462 (Konsantre) | 1 ml |
RA0402-C.1 | Nuclear Membrane Marker; Clone AE-5 (Konsantre) | 0.1 ml |
RA0402-C.5 | Nuclear Membrane Marker; Clone AE-5 (Konsantre) | 0.5 ml |
RA0401-C.1 | Nuclear Membrane Marker; Clone NM97 (Konsantre) | 0.1 ml |
RA0401-C.5 | Nuclear Membrane Marker; Clone NM97 (Konsantre) | 0.5 ml |
RA0251-C.1 | Nuclear Mitotic Apparatus Protein (NuMA); Clone A73-B/D12 (Konsantre) | 0.1 ml |
RA0251-C.5 | Nuclear Mitotic Apparatus Protein (NuMA); Clone A73-B/D12 (Konsantre) | 0.5 ml |
RA0404-C.1 | Nucleoli Marker; Clone NM95 (Konsantre) | 0.1 ml |
RA0404-C.5 | Nucleoli Marker; Clone NM95 (Konsantre) | 0.5 ml |
RA0242-C.1 | Nucleolin (Marker of Nucleoli); Clone NCL/902 (Konsantre) | 0.1 ml |
RA0242-C.5 | Nucleolin (Marker of Nucleoli); Clone NCL/902 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0252-C.1 | Ornithine Decarboxylase-1 (ODC-1); Clone ODC1/485 (Konsantre) | 0.1 ml |
RA0252-C.5 | Ornithine Decarboxylase-1 (ODC-1); Clone ODC1/485 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0076-C.1 | p21WAF1 (Tumor Suppressor Protein); Clone CIP1/823 (Konsantre) | 0.1 ml |
RA0076-C.5 | p21WAF1 (Tumor Suppressor Protein); Clone CIP1/823 (Konsantre) | 0.5 ml |
RA0473-C.1 | p21WAF1 (Tumor Suppressor Protein); Clone CIP1/823 & DCS-60.2 (Konsantre) | 0.1 ml |
RA0473-C.5 | p21WAF1 (Tumor Suppressor Protein); Clone CIP1/823 & DCS-60.2 (Konsantre) | 0.5 ml |
RA0473-C1 | p21WAF1 (Tumor Suppressor Protein); Clone CIP1/823 & DCS-60.2 (Konsantre) | 1 ml |
RA0075-C.1 | p21WAF1 (Tumor Suppressor Protein); Clone DCS-60.2 (Konsantre) | 0.1 ml |
RA0075-C.5 | p21WAF1 (Tumor Suppressor Protein); Clone DCS-60.2 (Konsantre) | 0.5 ml |
RA0472-C.1 | p21WAF1 (Tumor Suppressor Protein); Clone HJ21 (Konsantre) | 0.1 ml |
RA0472-C.5 | p21WAF1 (Tumor Suppressor Protein); Clone HJ21 (Konsantre) | 0.5 ml |
RA0472-C1 | p21WAF1 (Tumor Suppressor Protein); Clone HJ21 (Konsantre) | 1 ml |
RA0471-C.1 | p21WAF1 (Tumor Suppressor Protein); Clone SPM306 (Konsantre) | 0.1 ml |
RA0471-C.5 | p21WAF1 (Tumor Suppressor Protein); Clone SPM306 (Konsantre) | 0.5 ml |
RA0471-C1 | p21WAF1 (Tumor Suppressor Protein); Clone SPM306 (Konsantre) | 1 ml |
RA0074-C.1 | p21WAF1 (Tumor Suppressor Protein); Clone WA-1 (HJ21) (Konsantre) | 0.1 ml |
RA0074-C.5 | p21WAF1 (Tumor Suppressor Protein); Clone WA-1 (HJ21) (Konsantre) | 0.5 ml |
RA0079-C.1 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone DCS-72.F6 (Konsantre) | 0.1 ml |
RA0079-C.5 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone DCS-72.F6 (Konsantre) | 0.5 ml |
RA0475-C.1 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone DCS-72.F6 & KIP1/769 (Konsantre) | 0.1 ml |
RA0475-C.5 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone DCS-72.F6 & KIP1/769 (Konsantre) | 0.5 ml |
RA0475-C1 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone DCS-72.F6 & KIP1/769 (Konsantre) | 1 ml |
RA0078-C.1 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone KIP1/769 (Konsantre) | 0.1 ml |
RA0078-C.5 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone KIP1/769 (Konsantre) | 0.5 ml |
RA0474-C.1 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone SPM348 (Konsantre) | 0.1 ml |
RA0474-C.5 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone SPM348 (Konsantre) | 0.5 ml |
RA0474-C1 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone SPM348 (Konsantre) | 1 ml |
RA0077-C.1 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone SX53G8 (Konsantre) | 0.1 ml |
RA0077-C.5 | p27Kip1 (Mitotic Inhibitor/Suppressor Protein); Clone SX53G8 (Konsantre) | 0.5 ml |
RA0346-C.1 | p40 (deltaNp63) (Squamous, Basal, or Myoepithelial Cell Marker); Rabbit Polyclonal (Konsantre) | 0.1 ml |
RA0346-C.5 | p40 (deltaNp63) (Squamous, Basal, or Myoepithelial Cell Marker); Rabbit Polyclonal (Konsantre) | 0.5 ml |
RA0318-C.1 | p53 Tumor Suppressor Protein; Clone BP53-12 (Konsantre) | 0.1 ml |
RA0318-C.5 | p53 Tumor Suppressor Protein; Clone BP53-12 (Konsantre) | 0.5 ml |
RA0321-C.1 | p53 Tumor Suppressor Protein; Clone BP53-12 & DO-7 (Konsantre) | 0.1 ml |
RA0321-C.5 | p53 Tumor Suppressor Protein; Clone BP53-12 & DO-7 (Konsantre) | 0.5 ml |
RA0319-C.1 | p53 Tumor Suppressor Protein; Clone DO-7 (Konsantre) | 0.1 ml |
RA0319-C.5 | p53 Tumor Suppressor Protein; Clone DO-7 (Konsantre) | 0.5 ml |
RA0322-C.1 | p53 Tumor Suppressor Protein; Clone TRP/816 (Konsantre) | 0.1 ml |
RA0322-C.5 | p53 Tumor Suppressor Protein; Clone TRP/816 (Konsantre) | 0.5 ml |
RA0323-C.1 | p53 Tumor Suppressor Protein; Clone TRP/817 (Konsantre) | 0.1 ml |
RA0323-C.5 | p53 Tumor Suppressor Protein; Clone TRP/817 (Konsantre) | 0.5 ml |
RA0478-C.1 | p57Kip2 (Mitotic Inhibitor/Suppressor Protein); Clone 57P06 (Konsantre) | 0.1 ml |
RA0478-C.5 | p57Kip2 (Mitotic Inhibitor/Suppressor Protein); Clone 57P06 (Konsantre) | 0.5 ml |
RA0478-C1 | p57Kip2 (Mitotic Inhibitor/Suppressor Protein); Clone 57P06 (Konsantre) | 1 ml |
RA0081-C.1 | p57Kip2 (Mitotic Inhibitor/Suppressor Protein); Clone KIP2/880 (Konsantre) | 0.1 ml |
RA0081-C.5 | p57Kip2 (Mitotic Inhibitor/Suppressor Protein); Clone KIP2/880 (Konsantre) | 0.5 ml |
RA0080-C.1 | p57Kip2 (Mitotic Inhibitor/Suppressor Protein); Clone KP10 (Konsantre) | 0.1 ml |
RA0080-C.5 | p57Kip2 (Mitotic Inhibitor/Suppressor Protein); Clone KP10 (Konsantre) | 0.5 ml |
RA0477-C.1 | p57Kip2 (Mitotic Inhibitor/Suppressor Protein); Clone KP10 & KIP2/880 (Konsantre) | 0.1 ml |
RA0477-C.5 | p57Kip2 (Mitotic Inhibitor/Suppressor Protein); Clone KP10 & KIP2/880 (Konsantre) | 0.5 ml |
RA0477-C1 | p57Kip2 (Mitotic Inhibitor/Suppressor Protein); Clone KP10 & KIP2/880 (Konsantre) | 1 ml |
RA0476-C.1 | p57Kip2 (Mitotic Inhibitor/Suppressor Protein); Clone SPM308 (Konsantre) | 0.1 ml |
ARAŞTIRMA ANTİKORLARI RUO | DİLÜSYON ORANLARI | |
---|---|---|
RA0476-C.5 | p57Kip2 (Mitotic Inhibitor/Suppressor Protein); Clone SPM308 (Konsantre) | 0.5 ml |
RA0476-C1 | p57Kip2 (Mitotic Inhibitor/Suppressor Protein); Clone SPM308 (Konsantre) | 1 ml |
RA0272-C.1 | Parathyroid Hormone (PTH); Clone 3H9 (Konsantre) | 0.1 ml |
RA0272-C.5 | Parathyroid Hormone (PTH); Clone 3H9 (Konsantre) | 0.5 ml |
RA0273-C.1 | Parathyroid Hormone (PTH); Clone PTH1/911 (Konsantre) | 0.1 ml |
RA0273-C.5 | Parathyroid Hormone (PTH); Clone PTH1/911 (Konsantre) | 0.5 ml |
RA0466-C.1 | P-Cadherin (CDH3); Clone 12H6 (Konsantre) | 0.1 ml |
RA0466-C.5 | P-Cadherin (CDH3); Clone 12H6 (Konsantre) | 0.5 ml |
RA0466-C1 | P-Cadherin (CDH3); Clone 12H6 (Konsantre) | 1 ml |
RA0467-C.1 | P-Cadherin (CDH3); Clone 6A9 (Konsantre) | 0.1 ml |
RA0467-C.5 | P-Cadherin (CDH3); Clone 6A9 (Konsantre) | 0.5 ml |
RA0467-C1 | P-Cadherin (CDH3); Clone 6A9 (Konsantre) | 1 ml |
RA0253-C.1 | PCNA (Proliferating Cell Nuclear Antigen) (G1- & S-phase Marker); Clone PC10 (Konsantre) | 0.1 ml |
RA0253-C.5 | PCNA (Proliferating Cell Nuclear Antigen) (G1- & S-phase Marker); Clone PC10 (Konsantre) | 0.5 ml |
RA0254-C.1 | PDCD1 / PD1 / CD279 (Programmed Cell Death 1); Clone NAT105 (Konsantre) | 0.1 ml |
RA0254-C.5 | PDCD1 / PD1 / CD279 (Programmed Cell Death 1); Clone NAT105 (Konsantre) | 0.5 ml |
RA0255-C.1 | PDCD1 / PD1 / CD279 (Programmed Cell Death 1); Clone PDCD1/922 (Konsantre) | 0.1 ml |
RA0255-C.5 | PDCD1 / PD1 / CD279 (Programmed Cell Death 1); Clone PDCD1/922 (Konsantre) | 0.5 ml |
RA0501-C.1 | PD-L1 / PDCD1LG1 / CD274 / B7-H1; Clone PDL1/2746 (Konsantre) | 0.1 ml |
RA0501-C.5 | PD-L1 / PDCD1LG1 / CD274 / B7-H1; Clone PDL1/2746 (Konsantre) | 0.5 ml |
RA0501-C1 | PD-L1 / PDCD1LG1 / CD274 / B7-H1; Clone PDL1/2746 (Konsantre) | 1 ml |
RA0333-C.1 | PGP9.5 / UchL1 (pan-Neuronal Marker); Clone 31A3 (Konsantre) | 0.1 ml |
RA0333-C.5 | PGP9.5 / UchL1 (pan-Neuronal Marker); Clone 31A3 (Konsantre) | 0.5 ml |
RA0334-C.1 | PGP9.5 / UchL1 (pan-Neuronal Marker); Clone PARK5/775 (Konsantre) | 0.1 ml |
RA0334-C.5 | PGP9.5 / UchL1 (pan-Neuronal Marker); Clone PARK5/775 (Konsantre) | 0.5 ml |
RA0420-C.1 | Phosphotyrosine (P-Tyr); Clone PTR/793 (Konsantre) | 0.1 ml |
RA0420-C.5 | Phosphotyrosine (P-Tyr); Clone PTR/793 (Konsantre) | 0.5 ml |
RA0419-C.1 | Phosphotyrosine (P-Tyr); Clone PY20 (Konsantre) | 0.1 ml |
RA0419-C.5 | Phosphotyrosine (P-Tyr); Clone PY20 (Konsantre) | 0.5 ml |
RA0005-C.1 | Placental Alkaline Phosphatase (PLAP) (Germ Cell Tumor Marker); Clone ALP/870 (Konsantre) | 0.1 ml |
RA0005-C.5 | Placental Alkaline Phosphatase (PLAP) (Germ Cell Tumor Marker); Clone ALP/870 (Konsantre) | 0.5 ml |
RA0006-C.1 | Placental Alkaline Phosphatase (PLAP) (Germ Cell Tumor Marker); Clone GM022 (Konsantre) | 0.1 ml |
RA0006-C.5 | Placental Alkaline Phosphatase (PLAP) (Germ Cell Tumor Marker); Clone GM022 (Konsantre) | 0.5 ml |
RA0007-C.1 | Placental Alkaline Phosphatase (PLAP) (Germ Cell Tumor Marker); Clone PL8-F6 (Konsantre) | 0.1 ml |
RA0007-C.5 | Placental Alkaline Phosphatase (PLAP) (Germ Cell Tumor Marker); Clone PL8-F6 (Konsantre) | 0.5 ml |
RA0398-C.1 | Plasma Cell Marker; Clone LIV3G11 (7B18) (Konsantre) | 0.1 ml |
RA0398-C.5 | Plasma Cell Marker; Clone LIV3G11 (7B18) (Konsantre) | 0.5 ml |
RA0415-C.1 | PNL2 (Melanoma Associated Antigen); Clone PNL2 (Konsantre) | 0.1 ml |
RA0415-C.5 | PNL2 (Melanoma Associated Antigen); Clone PNL2 (Konsantre) | 0.5 ml |
RA0264-C.1 | Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker); Clone 3D3 (Konsantre) | 0.1 ml |
RA0264-C.5 | Podocalyxin (PODXL) (Hematopoietic Stem Cell Marker); Clone 3D3 (Konsantre) | 0.5 ml |
RA0351-C.1 | Podoplanin (Lymphatic Endothelium & Alveolar Epithelial Marker); Clone PDPN/601 (Konsantre) | 0.1 ml |
RA0351-C.5 | Podoplanin (Lymphatic Endothelium & Alveolar Epithelial Marker); Clone PDPN/601 (Konsantre) | 0.5 ml |
RA0495-C.1 | Podoplanin (PDPN) (Lymphatic Endothelial & Mesothelial Marker); Clone PDPN/1433 (Konsantre) | 0.1 ml |
RA0495-C.5 | Podoplanin (PDPN) (Lymphatic Endothelial & Mesothelial Marker); Clone PDPN/1433 (Konsantre) | 0.5 ml |
RA0495-C1 | Podoplanin (PDPN) (Lymphatic Endothelial & Mesothelial Marker); Clone PDPN/1433 (Konsantre) | 1 ml |
RA0263-C.1 | Progesterone Receptor (Marker of Progestin Dependence); Clone PR484 (Konsantre) | 0.1 ml |
RA0263-C.5 | Progesterone Receptor (Marker of Progestin Dependence); Clone PR484 (Konsantre) | 0.5 ml |
RA0269-C.1 | Prolactin Receptor (PRL-R); Clone B6.2 (Konsantre) | 0.1 ml |
RA0269-C.5 | Prolactin Receptor (PRL-R); Clone B6.2 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | DİLÜSYON ORANLARI | |
---|---|---|
RA0271-C.1 | Prolactin Receptor (PRL-R); Clone B6.2 & PRLR742 (Konsantre) | 0.1 ml |
RA0271-C.5 | Prolactin Receptor (PRL-R); Clone B6.2 & PRLR742 (Konsantre) | 0.5 ml |
RA0270-C.1 | Prolactin Receptor (PRL-R); Clone PRLR742 (Konsantre) | 0.1 ml |
RA0270-C.5 | Prolactin Receptor (PRL-R); Clone PRLR742 (Konsantre) | 0.5 ml |
RA0008-C.1 | Prostate Specific Antigen (PSA); Clone A67-B/E3 (Konsantre) | 0.1 ml |
RA0008-C.5 | Prostate Specific Antigen (PSA); Clone A67-B/E3 (Konsantre) | 0.5 ml |
RA0008-C1 | Prostate Specific Antigen (PSA); Clone A67-B/E3 (Konsantre) | 1 ml |
RA0009-C.1 | Prostate Specific Antigen (PSA); Clone KLK3/801 (Konsantre) | 0.1 ml |
RA0009-C.5 | Prostate Specific Antigen (PSA); Clone KLK3/801 (Konsantre) | 0.5 ml |
RA0300-C.1 | pS2 / pNR-2 / Trefoil Factor 1 (Estrogen-Regulated Protein); Clone GE2 (R47/94) (Konsantre) | 0.1 ml |
RA0300-C.5 | pS2 / pNR-2 / Trefoil Factor 1 (Estrogen-Regulated Protein); Clone GE2 (R47/94) (Konsantre) | 0.5 ml |
RA0452-C.1 | pS2 / pNR-2 / Trefoil Factor 1 (Estrogen-Regulated Protein); Clone TFF1/1091 (Konsantre) | 0.1 ml |
RA0452-C.5 | pS2 / pNR-2 / Trefoil Factor 1 (Estrogen-Regulated Protein); Clone TFF1/1091 (Konsantre) | 0.5 ml |
RA0452-C1 | pS2 / pNR-2 / Trefoil Factor 1 (Estrogen-Regulated Protein); Clone TFF1/1091 (Konsantre) | 1 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0026-C.1 | Renal Cell Carcinoma / gp200 (Carbonic Anhydrase IX); Clone 66.4.C2 (PN-15) (Konsantre) | 0.1 ml |
RA0026-C.5 | Renal Cell Carcinoma / gp200 (Carbonic Anhydrase IX); Clone 66.4.C2 (PN-15) (Konsantre) | 0.5 ml |
RA0027-C.1 | Renal Cell Carcinoma / gp200 (Carbonic Anhydrase IX); Clone CA9/781 (Konsantre) | 0.1 ml |
RA0027-C.5 | Renal Cell Carcinoma / gp200 (Carbonic Anhydrase IX); Clone CA9/781 (Konsantre) | 0.5 ml |
RA0446-C.1 | Retinol Binding Protein-1 (RBP1); Clone G4E4 (Konsantre) | 0.1 ml |
RA0446-C.5 | Retinol Binding Protein-1 (RBP1); Clone G4E4 (Konsantre) | 0.5 ml |
RA0446-C1 | Retinol Binding Protein-1 (RBP1); Clone G4E4 (Konsantre) | 1 ml |
RA0447-C.1 | Retinol Binding Protein-1 (RBP1); Clone RBP/872 (Konsantre) | 0.1 ml |
RA0447-C.5 | Retinol Binding Protein-1 (RBP1); Clone RBP/872 (Konsantre) | 0.5 ml |
RA0447-C1 | Retinol Binding Protein-1 (RBP1); Clone RBP/872 (Konsantre) | 1 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0285-C.1 | S100 (Astrocyte Marker); Clone 4C4.9 (Konsantre) | 0.1 ml |
RA0285-C.5 | S100 (Astrocyte Marker); Clone 4C4.9 (Konsantre) | 0.5 ml |
RA0286-C.1 | S100A7 / HID5 / Psoriasin (Proliferative Epithelial Cell Marker); Clone S100A7/542 (Konsantre) | 0.1 ml |
RA0286-C.5 | S100A7 / HID5 / Psoriasin (Proliferative Epithelial Cell Marker); Clone S100A7/542 (Konsantre) | 0.5 ml |
RA0106-C.1 | Secretory Component / ECM1; Clone ECM1/792 (Konsantre) | 0.1 ml |
RA0106-C.5 | Secretory Component / ECM1; Clone ECM1/792 (Konsantre) | 0.5 ml |
RA0105-C.1 | Secretory Component / ECM1; Clone SC05 (Konsantre) | 0.1 ml |
RA0105-C.5 | Secretory Component / ECM1; Clone SC05 (Konsantre) | 0.5 ml |
RA0449-C.1 | Sex Hormone Binding Globulin (SHBG); Clone SHBG/245 (Konsantre) | 0.1 ml |
RA0449-C.5 | Sex Hormone Binding Globulin (SHBG); Clone SHBG/245 (Konsantre) | 0.5 ml |
RA0449-C1 | Sex Hormone Binding Globulin (SHBG); Clone SHBG/245 (Konsantre) | 1 ml |
RA0229-C.1 | Smooth Muscle Myosin Heavy Chain (SM-MHC) (Leiomyosarcoma & Myoepithelial Cell Marker); Clone ID8 (Konsantre) | 0.1 ml |
RA0229-C.5 | Smooth Muscle Myosin Heavy Chain (SM-MHC) (Leiomyosarcoma & Myoepithelial Cell Marker); Clone ID8 (Konsantre) | 0.5 ml |
RA0230-C.1 | Smooth Muscle Myosin Heavy Chain (SM-MHC) (Leiomyosarcoma & Myoepithelial Cell Marker); Clone MYH11/923 (Konsantre) | 0.1 ml |
RA0230-C.5 | Smooth Muscle Myosin Heavy Chain (SM-MHC) (Leiomyosarcoma & Myoepithelial Cell Marker); Clone MYH11/923 (Konsantre) | 0.5 ml |
RA0228-C.1 | Smooth Muscle Myosin Heavy Chain (SM-MHC) (Leiomyosarcoma & Myoepithelial Cell Marker); Clone SMMS-1 (Konsantre) | 0.1 ml |
RA0228-C.5 | Smooth Muscle Myosin Heavy Chain (SM-MHC) (Leiomyosarcoma & Myoepithelial Cell Marker); Clone SMMS-1 (Konsantre) | 0.5 ml |
RA0594-C.1 | SOX10 (Melanoma Marker); Clone SOX10/991 (Konsantre) | 0.1 ml |
RA0594-C.5 | SOX10 (Melanoma Marker); Clone SOX10/991 (Konsantre) | 0.5 ml |
RA0594-C1 | SOX10 (Melanoma Marker); Clone SOX10/991 (Konsantre) | 1 ml |
RA0332-C.1 | SUMO-1; Clone SM1/495 (Konsantre) | 0.1 ml |
RA0332-C.5 | SUMO-1; Clone SM1/495 (Konsantre) | 0.5 ml |
RA0295-C.1 | SUMO-2/3; Clone SM23/496 (Konsantre) | 0.1 ml |
RA0295-C.5 | SUMO-2/3; Clone SM23/496 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0367-C.1 | TAG-72 (Tumor-Associated Glycoprotein); Clone B72.3 (Konsantre) | 0.1 ml |
RA0367-C.5 | TAG-72 (Tumor-Associated Glycoprotein); Clone B72.3 (Konsantre) | 0.5 ml |
RA0370-C.1 | TAG-72 (Tumor-Associated Glycoprotein); Clone B72.3 & CA72/733 (Konsantre) | 0.1 ml |
RA0370-C.5 | TAG-72 (Tumor-Associated Glycoprotein); Clone B72.3 & CA72/733 (Konsantre) | 0.5 ml |
RA0371-C.1 | TAG-72 (Tumor-Associated Glycoprotein); Clone B72.3 & CC49 (Konsantre) | 0.1 ml |
RA0371-C.5 | TAG-72 (Tumor-Associated Glycoprotein); Clone B72.3 & CC49 (Konsantre) | 0.5 ml |
RA0369-C.1 | TAG-72 (Tumor-Associated Glycoprotein); Clone CA72/733 (Konsantre) | 0.1 ml |
RA0369-C.5 | TAG-72 (Tumor-Associated Glycoprotein); Clone CA72/733 (Konsantre) | 0.5 ml |
RA0368-C.1 | TAG-72 (Tumor-Associated Glycoprotein); Clone CC49 (Konsantre) | 0.1 ml |
RA0368-C.5 | TAG-72 (Tumor-Associated Glycoprotein); Clone CC49 (Konsantre) | 0.5 ml |
RA0135-C.1 | Tenascin C (Stromal Marker For Epithelial Malignancy); Clone T2H5 (Konsantre) | 0.1 ml |
RA0135-C.5 | Tenascin C (Stromal Marker For Epithelial Malignancy); Clone T2H5 (Konsantre) | 0.5 ml |
RA0305-C.1 | TGF-alpha (Transforming Growth Factor alpha); Clone 1E8-G6 (Konsantre) | 0.1 ml |
RA0305-C.5 | TGF-alpha (Transforming Growth Factor alpha); Clone 1E8-G6 (Konsantre) | 0.5 ml |
RA0307-C.1 | TGF-alpha (Transforming Growth Factor alpha); Clone P/T1 (Konsantre) | 0.1 ml |
RA0307-C.5 | TGF-alpha (Transforming Growth Factor alpha); Clone P/T1 (Konsantre) | 0.5 ml |
RA0306-C.1 | TGF-alpha (Transforming Growth Factor alpha); Clone TG86 (Konsantre) | 0.1 ml |
RA0306-C.5 | TGF-alpha (Transforming Growth Factor alpha); Clone TG86 (Konsantre) | 0.5 ml |
RA0308-C.1 | TGF-alpha (Transforming Growth Factor alpha); Clone TG86 & P/T1 (Konsantre) | 0.1 ml |
RA0308-C.5 | TGF-alpha (Transforming Growth Factor alpha); Clone TG86 & P/T1 (Konsantre) | 0.5 ml |
RA0327-C.1 | Thymidylate Synthase (5-FU Resistance Marker); Clone TMS715 (Konsantre) | 0.1 ml |
RA0327-C.5 | Thymidylate Synthase (5-FU Resistance Marker); Clone TMS715 (Konsantre) | 0.5 ml |
RA0326-C.1 | Thymidylate Synthase (5-FU Resistance Marker); Clone TS106 (Konsantre) | 0.1 ml |
RA0326-C.5 | Thymidylate Synthase (5-FU Resistance Marker); Clone TS106 (Konsantre) | 0.5 ml |
RA0328-C.1 | Thymidylate Synthase (5-FU Resistance Marker); Clone TS106 & TMS715 (Konsantre) | 0.1 ml |
RA0328-C.5 | Thymidylate Synthase (5-FU Resistance Marker); Clone TS106 & TMS715 (Konsantre) | 0.5 ml |
RA0301-C.1 | Thyroglobulin (Thyroidal Cell Marker); Clone 2H11 (Konsantre) | 0.1 ml |
RA0301-C.5 | Thyroglobulin (Thyroidal Cell Marker); Clone 2H11 (Konsantre) | 0.5 ml |
RA0303-C.1 | Thyroglobulin (Thyroidal Cell Marker); Clone 2H11 & 6E1 (Konsantre) | 0.1 ml |
RA0303-C.5 | Thyroglobulin (Thyroidal Cell Marker); Clone 2H11 & 6E1 (Konsantre) | 0.5 ml |
RA0303-C1 | Thyroglobulin (Thyroidal Cell Marker); Clone 2H11 & 6E1 (Konsantre) | 1 ml |
RA0302-C.1 | Thyroglobulin (Thyroidal Cell Marker); Clone 6E1 (Konsantre) | 0.1 ml |
RA0302-C.5 | Thyroglobulin (Thyroidal Cell Marker); Clone 6E1 (Konsantre) | 0.5 ml |
RA0304-C.1 | Thyroglobulin (Thyroidal Cell Marker); Clone TGB04 & TGB05 (Konsantre) | 0.1 ml |
RA0304-C.5 | Thyroglobulin (Thyroidal Cell Marker); Clone TGB04 & TGB05 (Konsantre) | 0.5 ml |
RA0309-C.1 | TIMP-3 (Tissue Inhibitor of Metalloproteinase-3); Rabbit Polyclonal (Konsantre) | 0.1 ml |
RA0309-C.5 | TIMP-3 (Tissue Inhibitor of Metalloproteinase-3); Rabbit Polyclonal (Konsantre) | 0.5 ml |
RA0314-C.1 | TNF-alpha (Tumor Necrosis Factor alpha); Clone 4C6-H8 (Konsantre) | 0.1 ml |
RA0314-C.5 | TNF-alpha (Tumor Necrosis Factor alpha); Clone 4C6-H8 (Konsantre) | 0.5 ml |
RA0315-C.1 | TNF-alpha (Tumor Necrosis Factor alpha); Clone P/T2 (Konsantre) | 0.1 ml |
RA0315-C.5 | TNF-alpha (Tumor Necrosis Factor alpha); Clone P/T2 (Konsantre) | 0.5 ml |
RA0316-C.1 | TNF-alpha (Tumor Necrosis Factor alpha); Clone TNF706 (Konsantre) | 0.1 ml |
RA0316-C.5 | TNF-alpha (Tumor Necrosis Factor alpha); Clone TNF706 (Konsantre) | 0.5 ml |
RA0317-C.1 | TNF-alpha (Tumor Necrosis Factor alpha); Clone TNF706 & P/T2 (Konsantre) | 0.1 ml |
RA0317-C.5 | TNF-alpha (Tumor Necrosis Factor alpha); Clone TNF706 & P/T2 (Konsantre) | 0.5 ml |
RA0520-C.1 | Topoisomerase (DNA) I, Mitochondrial (TOP1MT); Clone TOP1MT/488 (Konsantre) | 0.1 ml |
RA0520-C.5 | Topoisomerase (DNA) I, Mitochondrial (TOP1MT); Clone TOP1MT/488 (Konsantre) | 0.5 ml |
RA0520-C1 | Topoisomerase (DNA) I, Mitochondrial (TOP1MT); Clone TOP1MT/488 (Konsantre) | 1 ml |
RA0422-C.1 | TRAcP (Tartrate-Resistant Acid Phosphatase); Clone ACP5/1070 (Konsantre) | 0.1 ml |
RA0422-C.5 | TRAcP (Tartrate-Resistant Acid Phosphatase); Clone ACP5/1070 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | DİLÜSYON ORANLARI | |
---|---|---|
RA0451-C.1 | Transgelin (SM22-alpha); Clone TAGLN/247 (Konsantre) | 0.1 ml |
RA0451-C.5 | Transgelin (SM22-alpha); Clone TAGLN/247 (Konsantre) | 0.5 ml |
RA0451-C1 | Transgelin (SM22-alpha); Clone TAGLN/247 (Konsantre) | 1 ml |
RA0454-C.1 | TRIM29 (Lung Squamous Cell Carcinoma Marker); Clone TRIM29/1041 (Konsantre) | 0.1 ml |
RA0454-C.5 | TRIM29 (Lung Squamous Cell Carcinoma Marker); Clone TRIM29/1041 (Konsantre) | 0.5 ml |
RA0454-C1 | TRIM29 (Lung Squamous Cell Carcinoma Marker); Clone TRIM29/1041 (Konsantre) | 1 ml |
RA0310-C.1 | TTF-1 / NKX2.1 (Thyroid & Lung Epithelial Marker); Clone 8G7G3/1 (Konsantre) | 0.1 ml |
RA0310-C.5 | TTF-1 / NKX2.1 (Thyroid & Lung Epithelial Marker); Clone 8G7G3/1 (Konsantre) | 0.5 ml |
RA0313-C.1 | TTF-1 / NKX2.1 (Thyroid & Lung Epithelial Marker); Clone 8G7G3/1 & NX2.1/690 (Konsantre) | 0.1 ml |
RA0313-C.5 | TTF-1 / NKX2.1 (Thyroid & Lung Epithelial Marker); Clone 8G7G3/1 & NX2.1/690 (Konsantre) | 0.5 ml |
RA0312-C.1 | TTF-1 / NKX2.1 (Thyroid & Lung Epithelial Marker); Clone NX2.1/690 (Konsantre) | 0.1 ml |
RA0312-C.5 | TTF-1 / NKX2.1 (Thyroid & Lung Epithelial Marker); Clone NX2.1/690 (Konsantre) | 0.5 ml |
RA0324-C.1 | Tubulin-alpha (Microtubule Marker); Clone TU-02 (Konsantre) | 0.1 ml |
RA0324-C.5 | Tubulin-alpha (Microtubule Marker); Clone TU-02 (Konsantre) | 0.5 ml |
RA0325-C.1 | Tubulin-alpha (Microtubule Marker); Clone TU-16 (Konsantre) | 0.1 ml |
RA0325-C.5 | Tubulin-alpha (Microtubule Marker); Clone TU-16 (Konsantre) | 0.5 ml |
RA0365-C.1 | Tumor Endothelial Marker 8 (TEM8) / Anthrax Toxin Receptor 1; Clone TEM8/589 (Konsantre) | 0.1 ml |
RA0365-C.5 | Tumor Endothelial Marker 8 (TEM8) / Anthrax Toxin Receptor 1; Clone TEM8/589 (Konsantre) | 0.5 ml |
RA0330-C.1 | Tyrosinase (Melanoma Marker); Clone OCA1/812 (Konsantre) | 0.1 ml |
RA0330-C.5 | Tyrosinase (Melanoma Marker); Clone OCA1/812 (Konsantre) | 0.5 ml |
RA0329-C.1 | Tyrosinase (Melanoma Marker); Clone T311 (Konsantre) | 0.1 ml |
RA0329-C.5 | Tyrosinase (Melanoma Marker); Clone T311 (Konsantre) | 0.5 ml |
RA0331-C.1 | Tyrosinase (Melanoma Marker); Clone T311 & OCA1/812 (Konsantre) | 0.1 ml |
RA0331-C.5 | Tyrosinase (Melanoma Marker); Clone T311 & OCA1/812 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0338-C.1 | Vimentin (Mesenchymal Cell Marker); Clone LN6 (Konsantre) | 0.1 ml |
RA0338-C.5 | Vimentin (Mesenchymal Cell Marker); Clone LN6 (Konsantre) | 0.5 ml |
RA0337-C.1 | Vimentin (Mesenchymal Cell Marker); Clone VM452 (Konsantre) | 0.1 ml |
RA0337-C.5 | Vimentin (Mesenchymal Cell Marker); Clone VM452 (Konsantre) | 0.5 ml |
RA0339-C.1 | von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker); Clone 3E2D10 (Konsantre) | 0.1 ml |
RA0339-C.5 | von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker); Clone 3E2D10 (Konsantre) | 0.5 ml |
RA0341-C.1 | von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker); Clone 3E2D10 & VWF635 (Konsantre) | 0.1 ml |
RA0341-C.5 | von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker); Clone 3E2D10 & VWF635 (Konsantre) | 0.5 ml |
RA0342-C.1 | von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker); Clone IIIE2.34 (Konsantre) | 0.1 ml |
RA0342-C.5 | von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker); Clone IIIE2.34 (Konsantre) | 0.5 ml |
RA0340-C.1 | von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker); Clone VWF635 (Konsantre) | 0.1 ml |
RA0340-C.5 | von Willebrand Factor / Factor VIII Related-Ag (Endothelial Marker); Clone VWF635 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0343-C.1 | Wilm's Tumor 1 (WT1) (Wilm's Tumor & Mesothelial Marker); Clone 6F-H2 (Konsantre) | 0.1 ml |
RA0343-C.5 | Wilm's Tumor 1 (WT1) (Wilm's Tumor & Mesothelial Marker); Clone 6F-H2 (Konsantre) | 0.5 ml |
RA0344-C.1 | Wilm's Tumor 1 (WT1) (Wilm's Tumor & Mesothelial Marker); Clone WMT/857 (Konsantre) | 0.1 ml |
RA0344-C.5 | Wilm's Tumor 1 (WT1) (Wilm's Tumor & Mesothelial Marker); Clone WMT/857 (Konsantre) | 0.5 ml |
ARAŞTIRMA ANTİKORLARI RUO | AMBALAJ | |
---|---|---|
RA0453-C.1 | ZAP-70 (Chronic Lymphocytic Leukemia Marker); Clone ZAP70/528 (Konsantre) | 0.1 ml |
RA0453-C.5 | ZAP-70 (Chronic Lymphocytic Leukemia Marker); Clone ZAP70/528 (Konsantre) | 0.5 ml |
RA0453-C1 | ZAP-70 (Chronic Lymphocytic Leukemia Marker); Clone ZAP70/528 (Konsantre) | 1 ml |
RA0345-C.1 | ZAP-70 [Zeta-chain (TCR) Associated Protein Kinase 70kDa]; Clone 2F3.2 (Konsantre) | 0.1 ml |
RA0345-C.5 | ZAP-70 [Zeta-chain (TCR) Associated Protein Kinase 70kDa]; Clone 2F3.2 (Konsantre) | 0.5 ml |